Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Jun. 30, 2024 | Aug. 12, 2024 | Dec. 31, 2023 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Jun. 30, 2024 | ||
Document Fiscal Year Focus | 2024 | ||
Document Fiscal Period Focus | FY | ||
Trading Symbol | QNST | ||
Entity Registrant Name | QuinStreet, Inc. | ||
Entity Central Index Key | 0001117297 | ||
Current Fiscal Year End Date | --06-30 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Common Stock, Shares Outstanding | 55,976,094 | ||
Entity Public Float | $ 675,599,058 | ||
ICFR Auditor Attestation Flag | true | ||
Document Financial Statement Error Correction [Flag] | false | ||
Entity Shell Company | false | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
Entity File Number | 001-34628 | ||
Entity Tax Identification Number | 77-0512121 | ||
Entity Address, Address Line One | 950 Tower Lane | ||
Entity Address, Address Line Two | 12th Floor | ||
Entity Address, City or Town | Foster City | ||
Entity Address, State or Province | CA | ||
Entity Incorporation State Country Code | DE | ||
Entity Address, Postal Zip Code | 94404 | ||
City Area Code | 650 | ||
Local Phone Number | 587-7700 | ||
Title of 12(b) Security | Common Stock, par value $0.001 per share | ||
Security Exchange Name | NASDAQ | ||
Documents Incorporated by Reference | Portions of the registrant’s definitive proxy statement relating to its 2024 annual stockholders’ meeting are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Entity Interactive Data Current | Yes | ||
Auditor Name | PricewaterhouseCoopers LLP | ||
Auditor Location | San Francisco, California | ||
Auditor Firm ID | 238 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 50,488 | $ 73,677 |
Accounts receivable, net of allowances and reserves of $2,106 and $3,722 as of June 30, 2024 and 2023 | 111,786 | 67,748 |
Prepaid expenses and other assets | 6,813 | 9,779 |
Total current assets | 169,087 | 151,204 |
Property and equipment, net | 19,858 | 16,749 |
Operating lease right-of-use assets | 10,440 | 3,536 |
Goodwill | 125,056 | 121,141 |
Intangible assets, net | 38,008 | 38,700 |
Other assets, noncurrent | 6,097 | 5,825 |
Total assets | 368,546 | 337,155 |
Current liabilities: | ||
Accounts payable | 48,204 | 37,926 |
Accrued liabilities | 68,822 | 44,019 |
Other liabilities | 9,372 | 7,875 |
Total current liabilities | 126,398 | 89,820 |
Operating lease liabilities, noncurrent | 7,879 | 1,261 |
Other liabilities, noncurrent | 17,444 | 16,273 |
Total liabilities | 151,721 | 107,354 |
Commitments and contingencies (See Note 11) | 0 | 0 |
Stockholders' equity: | ||
Common stock: $0.001 par value; 100,000,000 shares authorized; 55,473,439 and 54,192,928 shares issued and outstanding as of June 30, 2024 and 2023 | 55 | 54 |
Additional paid-in capital | 347,449 | 329,093 |
Accumulated other comprehensive loss | (268) | (266) |
Accumulated deficit | (130,411) | (99,080) |
Total stockholders' equity | 216,825 | 229,801 |
Total liabilities and stockholders' equity | $ 368,546 | $ 337,155 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, net of allowances and reserves | $ 2,106 | $ 3,722 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 55,473,439 | 54,192,928 |
Common stock, shares outstanding | 55,473,439 | 54,192,928 |
Consolidated Statements of Oper
Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | ||
Income Statement [Abstract] | ||||
Net revenue | $ 613,514 | $ 580,624 | $ 582,099 | |
Cost of revenue | [1] | 567,268 | 532,101 | 528,368 |
Gross profit | 46,246 | 48,523 | 53,731 | |
Operating expenses: | ||||
Product development | [1] | 30,045 | 28,893 | 21,906 |
Sales and marketing | [1] | 13,607 | 12,542 | 11,042 |
General and administrative | [1] | 30,659 | 27,904 | 25,501 |
Operating loss | (28,065) | (20,816) | (4,718) | |
Interest income | 408 | 296 | 10 | |
Interest expense | (680) | (790) | (1,075) | |
Other (expense) income, net | (2,059) | (52) | 21 | |
Loss before income taxes | (30,396) | (21,362) | (5,762) | |
(Provision for) benefit from income taxes | (935) | (47,504) | 514 | |
Net loss | (31,331) | (68,866) | (5,248) | |
Comprehensive loss: | ||||
Net loss | (31,331) | (68,866) | (5,248) | |
Other comprehensive loss: | ||||
Foreign currency translation adjustment | (2) | (5) | (6) | |
Comprehensive loss | $ (31,333) | $ (68,871) | $ (5,254) | |
Net loss per share, basic | [2] | $ (0.57) | $ (1.28) | $ (0.1) |
Net loss per share, diluted | [2] | $ (0.57) | $ (1.28) | $ (0.1) |
Weighted-average shares of common stock used in computing net loss per share, basic | 54,917 | 53,799 | 54,339 | |
Weighted-average shares of common stock used in computing net loss per share, diluted | 54,917 | 53,799 | 54,339 | |
[1] Cost of revenue and operating expenses include stock-based compensation expense as follows: Diluted net loss per share does not reflect any potential common stock relating to stock options, restricted stock units, or shares issuable related to the ESPP due to net loss incurred in fiscal years 2024, 2023 and 2022. The assumed issuance of any additional shares would be anti-dilutive. |
Consolidated Statements of Op_2
Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Cost of revenue [Member] | |||
Stock-based compensation | $ 8,409 | $ 7,923 | $ 7,475 |
Product development [Member] | |||
Stock-based compensation | 3,147 | 2,880 | 2,575 |
Sales and marketing [Member] | |||
Stock-based compensation | 2,968 | 2,298 | 2,378 |
General and administrative [Member] | |||
Stock-based compensation | $ 9,177 | $ 5,685 | $ 6,078 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Total | Common Stock [Member] | Treasury Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Other Comprehensive Loss [Member] | Accumulated Deficit [Member] |
Beginning Balance at Jun. 30, 2022 | $ 286,000 | $ 53 | $ 316,422 | $ (261) | $ (30,214) | |
Beginning Balance, Shares at Jun. 30, 2022 | 53,356,875 | |||||
Issuance of common stock upon exercise of stock options | $ 587 | 587 | ||||
Issuance of common stock upon exercise of stock options, Shares | 109,359 | 109,359 | ||||
Release of restricted stock, net of share settlement | $ 1 | (1) | ||||
Release of restricted stock, net of share settlement, Shares | 851,241 | |||||
Issuance of common stock under the employee stock purchase plan | $ 2,687 | 2,687 | ||||
Issuance of common stock under the employee stock purchase plan, Shares | 278,646 | |||||
Stock-based compensation expense | 18,840 | 18,840 | ||||
Withholding taxes related to release of restricted stock, net of share settlement | (5,389) | (5,389) | ||||
Repurchase of common stock | (4,053) | $ (4,053) | ||||
Repurchase of common stock, Shares | (403,193) | |||||
Retirement of treasury stock | $ 4,100 | $ 4,053 | (4,053) | |||
Retirement of treasury stock, Shares | 403,193 | (403,193) | 403,193 | |||
Net loss | $ (68,866) | (68,866) | ||||
Other comprehensive loss | (5) | (5) | ||||
Ending Balance at Jun. 30, 2023 | $ 229,801 | $ 54 | 329,093 | (266) | (99,080) | |
Ending Balance, Shares at Jun. 30, 2023 | 54,192,928 | 54,192,928 | ||||
Issuance of common stock upon exercise of stock options | $ 918 | 918 | ||||
Issuance of common stock upon exercise of stock options, Shares | 217,926 | 217,926 | ||||
Release of restricted stock, net of share settlement | $ 1 | (1) | ||||
Release of restricted stock, net of share settlement, Shares | 992,809 | |||||
Issuance of common stock under the employee stock purchase plan | $ 2,573 | 2,573 | ||||
Issuance of common stock under the employee stock purchase plan, Shares | 317,394 | |||||
Stock-based compensation expense | 23,754 | 23,754 | ||||
Withholding taxes related to release of restricted stock, net of share settlement | (6,688) | (6,688) | ||||
Repurchase of common stock | (2,200) | $ (2,200) | ||||
Repurchase of common stock, Shares | (247,618) | |||||
Retirement of treasury stock | $ 2,200 | $ 2,200 | (2,200) | |||
Retirement of treasury stock, Shares | 247,618 | (247,618) | 247,618 | |||
Net loss | $ (31,331) | (31,331) | ||||
Other comprehensive loss | (2) | (2) | ||||
Ending Balance at Jun. 30, 2024 | $ 216,825 | $ 55 | $ 347,449 | $ (268) | $ (130,411) | |
Ending Balance, Shares at Jun. 30, 2024 | 55,473,439 | 55,473,439 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Cash Flows from Operating Activities | |||
Net loss | $ (31,331) | $ (68,866) | $ (5,248) |
Adjustments to reconcile net loss to net cash provided by operating activities: | |||
Depreciation and amortization | 23,957 | 19,155 | 16,961 |
Stock-based compensation | 23,701 | 18,786 | 18,506 |
Impairment of investment in equity securities | 2,000 | 0 | 0 |
Provision for sales returns and doubtful accounts receivable | 896 | 2,745 | 581 |
Deferred income taxes | 597 | 47,214 | (791) |
Non-cash lease expense | (513) | (1,081) | (1,043) |
Change in the fair value of contingent consideration | 0 | 0 | (926) |
Other adjustments, net | (256) | (149) | 482 |
Changes in assets and liabilities: | |||
Accounts receivable | (44,934) | 10,936 | 5,543 |
Prepaid expenses and other assets | 2,966 | (4,802) | 3,003 |
Other assets, noncurrent | (875) | 124 | (788) |
Accounts payable | 10,480 | (4,770) | (2,885) |
Accrued liabilities | 25,351 | (7,454) | (4,723) |
Net cash provided by operating activities | 12,039 | 11,838 | 28,672 |
Cash Flows from Investing Activities | |||
Internal software development costs | (11,377) | (11,942) | (4,672) |
Capital expenditures | (5,348) | (3,062) | (2,842) |
Acquisitions, net of cash acquired | (4,510) | 0 | (1,797) |
Other investing activities | (1,500) | (121) | 86 |
Net cash used in investing activities | (22,735) | (15,125) | (9,225) |
Cash Flows from Financing Activities | |||
Proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan | 3,491 | 3,219 | 1,854 |
Payment of withholding taxes related to release of restricted stock, net of share settlement | (6,688) | (5,389) | (7,342) |
Post-closing payments and contingent consideration related to acquisitions | (7,026) | (11,643) | (12,559) |
Repurchase of common stock | (2,288) | (5,646) | (15,268) |
Net cash used in financing activities | (12,511) | (19,459) | (33,315) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 18 | (15) | (12) |
Net decrease in cash, cash equivalents and restricted cash | (23,189) | (22,761) | (13,880) |
Cash, cash equivalents and restricted cash at beginning of period | 73,692 | 96,453 | 110,333 |
Cash, cash equivalents and restricted cash at end of period | 50,503 | 73,692 | 96,453 |
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets | |||
Cash and cash equivalents | 50,488 | 73,677 | 96,439 |
Restricted cash included in other assets, noncurrent | $ 15 | $ 15 | $ 14 |
Restricted Cash, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other assets, noncurrent | Other assets, noncurrent | Other assets, noncurrent |
Total cash, cash equivalents and restricted cash | $ 50,503 | $ 73,692 | $ 96,453 |
Supplemental Disclosure of Cash Flow Information | |||
Cash paid for income taxes | 470 | 372 | 396 |
Supplemental Disclosure of Noncash Investing and Financing Activities | |||
Post-closing payments unpaid at acquisition date (See Note 6) | 7,161 | 0 | 2,785 |
Contingent consideration unpaid at acquisition date (See Note 6) | 2,100 | 0 | 0 |
Retirement of treasury stock (See Note 13) | (2,200) | (4,053) | (16,950) |
Purchases of property and equipment included in accrued liabilities | $ 846 | $ 1,228 | $ 613 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Pay vs Performance Disclosure | |||
Net Income (Loss) | $ (31,331) | $ (68,866) | $ (5,248) |
Insider Trading Arrangements
Insider Trading Arrangements | 12 Months Ended |
Jun. 30, 2024 shares | |
Trading Arrangements, by Individual | |
Material Terms of Trading Arrangement | On June 5, 2024 , Gregory Wong , Chief Financial Officer , entered into a Rule 10b5-1 Plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. Mr. Wong's Rule 10b5-1 Plan provides for the potential sale (beginning on September 12, 2024) of all of the (net) shares of up to 111,416 (gross) shares of the Company's common stock, consisting of (i) 50,977 shares of common stock and (ii) the net shares (not yet determinable) after shares are withheld to satisfy tax withholding obligations, issuable upon the vesting of up to 60,439 shares of restricted stock and performance-based restricted stock granted to Mr. Wong by the Company. Mr. Wong’s Rule 10b5-1 Plan expires on February 20, 2025 , or upon the earlier completion of all the transactions authorized thereunder. |
Gregory Wong [Member] | |
Trading Arrangements, by Individual | |
Name | Gregory Wong |
Title | Chief Financial Officer |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | June 5, 2024 |
Expiration Date | February 20, 2025 |
Arrangement Duration | 161 days |
Aggregate Available | 111,416 |
Common Stock Shares [Member] | Gregory Wong [Member] | |
Trading Arrangements, by Individual | |
Aggregate Available | 50,977 |
Restricted Stock and Performance-Based Restricted Stock [Member] | Gregory Wong [Member] | |
Trading Arrangements, by Individual | |
Aggregate Available | 60,439 |
Insider Trading Policies and Pr
Insider Trading Policies and Procedures | 12 Months Ended |
Jun. 30, 2024 | |
Insider Trading Policies and Procedures [Line Items] | |
Insider Trading Policies and Procedures Adopted | true |
The Company
The Company | 12 Months Ended |
Jun. 30, 2024 | |
Organization [Abstract] | |
The Company | 1. The Company QuinStreet, Inc. (the “Company”) is a leader in performance marketplaces and technologies for the financial services and home services industries. The Company was incorporated in California in April 1999 and reincorporated in Delaware in December 2009. The Company specializes in customer acquisition for clients in high value, information-intensive markets or “verticals,” including financial services and home services. The corporate headquarters are located in Foster City, California, with additional offices throughout the United States, India and Mexico. The majority of the Company’s operations and revenue are in North America. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | 2. Summary of Significant Accounting Policies Principles of Consolidation The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Reclassification Certain amounts in fiscal year 2023 consolidated financial statements have been reclassified to conform with current year presentation. These reclassifications had no effect on previously reported totals for assets, liabilities, stockholders’ equity, cash flows or net income. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. These estimates are based on information available as of the date of the financial statements; therefore, actual results could differ from those estimates. Revenue Recognition The Company derives revenue primarily from fees earned through the delivery of qualified inquiries such as clicks, leads, calls, applications, or customers. The Company recognizes revenue when the Company transfers promised goods or services to clients in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The Company recognizes revenue pursuant to the five-step framework contained in ASC 606, Revenue from Contracts with Customers: (i) identify the contract with a client; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations. As part of determining whether a contract exists, probability of collection is assessed on a client-by-client basis at the outset of the contract. Clients are subjected to a credit review process that evaluates the clients’ financial position and the ability and intention to pay. If it is determined from the outset of an arrangement that the client does not have the ability or intention to pay, the Company will conclude that a contract does not exist and will continuously reassess its evaluation until the Company is able to conclude that a contract does exist. Generally, the Company’s contracts specify the period of time as one month, but in some instances the term may be longer. However, for most of the Company’s contracts with clients, either party can terminate the contract at any time without penalty. Consequently, enforceable rights and obligations only exist on a day-to-day basis, resulting in individual daily contracts during the specified term of the contract or until one party terminates the contract prior to the end of the specified term. The Company has assessed the services promised in its contracts with clients and has identified one performance obligation, which is a series of distinct services. Depending on the client’s needs, these services consist of a specified or an unlimited number of clicks, leads, calls, applications, customers, etc. (hereafter collectively referred to as “marketing results”) to be delivered over a period of time. The Company satisfies these performance obligations over time as the services are provided. The Company does not promise to provide any other significant goods or services to its clients. Transaction price is measured based on the consideration that the Company expects to receive from a contract with a client. The Company’s contracts with clients contain variable consideration as the price for an individual marketing result varies on a day-to-day basis depending on the market-driven amount a client has committed to pay. However, because the Company ensures the stated period of its contracts does not generally span multiple reporting periods, the contractual amount within a period is based on the number of marketing results delivered within the period. Therefore, the transaction price for any given period is fixed and no estimation of variable consideration is required. If a marketing result delivered to a client does not meet the contractual requirements associated with that marketing result, the Company’s contracts allow for clients to return a marketing result generally within 5-10 days of having received the marketing result. Such returns are factored into the amount billed to the client on a monthly basis and consequently result in a reduction to revenue in the same month the marketing result is delivered. No warranties are offered to the Company’s clients. The Company does not allocate transaction price as the Company has only one performance obligation and its contracts do not generally span multiple periods. Taxes collected from clients and remitted to governmental authorities are not included in revenue. The Company elected to use the practical expedient which allows the Company to record sales commissions as expense as incurred when the amortization period would have been one year or less. The Company bills clients monthly in arrears for the marketing results delivered during the preceding month. The Company’s standard payment terms are 30-60 days. Consequently, the Company does not have significant financing components in its arrangements. Separately from the agreements the Company has with clients, the Company has agreements with Internet search companies, third-party publishers and strategic partners that it engages with to generate targeted marketing results for the Company’s clients. The Company receives a fee from its clients and separately pays a fee to the Internet search companies, third-party publishers and strategic partners. The Company evaluates whether it is the principal (i.e., report revenue on a gross basis) or agent (i.e., report revenue on a net basis). In doing so, the Company first evaluates whether it controls the goods or services before they are transferred to the clients. If the Company controls the goods or services before they are transferred to the clients, the Company is the principal in the transaction. As a result, the fees paid by the Company’s clients are recognized as revenue and the fees paid to its Internet search companies, third-party publishers and strategic partners are included in cost of revenue. If the Company does not control the goods or services before they are transferred to the clients, the Company is the agent in the transaction and recognizes revenue on a net basis. The Company has one subsidiary, CloudControlMedia, LLC (“CCM”) , which provides performance marketing agency and technology services to clients in financial services, education and other markets, recognizing revenue on a net basis. Determining whether the Company controls the goods or services before they are transferred to the clients may require judgment. Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company’s investment portfolio consists of money market funds. Cash is deposited with financial institutions that management believes are creditworthy. To date, the Company has not experienced any material losses on its investment portfolio. The Company maintains contracts with its clients, most of which are cancelable with little or no prior notice. In addition, these contracts do not contain penalty provisions for cancellation before the end of the contract term. The Company had one client that accounted for 12 %, 20 % and 17 % of net revenue in fiscal years 2024, 2023 and 2022. The Company had two client s that accounted for 13 % and 11 % of net accounts receivable as of June 30, 2024. No other client accounted for 10 % or more of net revenue in fiscal years 2024, 2023 and 2022, or 10 % or more of net accounts receivable as of June 30, 2024 and 2023. Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the reporting date. The Company estimates and categorizes the fair value of its financial instruments by applying the following hierarchy: Level 1 — Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to directly access. Level 2 — Valuations based on quoted prices for similar assets or liabilities; valuations for interest-bearing securities based on non-daily quoted prices in active markets; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 3 — Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The Company’s financial instruments consist principally of cash equivalents, accounts receivable, accounts payable, post-closing payments and contingent consideration related to acquisitions. The recorded values of the Company’s accounts receivable and accounts payable approximate their current fair values due to the relatively short-term nature of these accounts. See Note 5, Fair Value Measurements, for additional information regarding fair value measurements. Cash and Cash Equivalents All highly liquid investments with maturities of three months or less at the date of purchase are classified as cash equivalents on the Company’s consolidated balance sheets. Accounts Receivable and Allowances The Company’s accounts receivable are derived from clients located principally in the United States. The Company performs ongoing credit evaluation of its customers and generally does not require collateral. The Company makes estimates of expected credit losses for the allowance for doubtful accounts and allowance for unbilled receivables based upon its assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The following table presents the changes in the Company’s allowance for credit losses for the periods indicated (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Balance at beginning of the year $ 2,092 $ 120 $ 120 Write-offs charged against the allowance ( 1,277 ) — — Provision for credit losses — 1,972 — Balance at end of the year $ 815 $ 2,092 $ 120 The revenue reserve was $ 1.3 million and $ 1.6 million as of June 30, 2024 and 2023. The total allowance for credit losses and revenue reserve was $ 2.1 million and $ 3.7 million as of June 30, 2024 and 2023. Property and Equipment Property and equipment are stated at cost less accumulated depreciation and amortization, and are depreciated on a straight-line basis over the estimated useful lives of the assets, as follows: Computer equipment 3 years Software 3 years Furniture and fixtures 3 to 5 years Leasehold improvements the shorter of the lease term or the estimated useful lives of the improvements Internal Software Development Costs The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the development phase are capitalized and amortized over the product’s estimated useful life if the product is expected to have a useful life beyond six months . Costs associated with repair or maintenance of existing sites or the development of website content are included within cost of revenue in the Company’s consolidated statements of operations and comprehensive loss . The Company’s policy is to amortize capitalized internal software development costs on a product-by-product basis using the straight-line method over the estimated economic life of the application, which is generally two years . The Company capitalized internal software development costs of $ 10.9 million and $ 12.8 million in fiscal years 2024 and 2023. Amortization of internal software development costs is reflected within cost of revenue in the Company’s consolidated statements of operations and comprehensive loss . Leases At the commencement date of a lease, the Company recognizes lease liabilities which represent its obligation to make lease payments, and right-of-use (“ROU”) assets which represent its right to use the underlying asset during the lease term. The lease liability is measured at the present value of lease payments over the lease term. As the Company’s leases typically do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the lease commencement date. The ROU asset is measured at cost, which includes the initial measurement of the lease liability and initial direct costs incurred by the Company and excludes lease incentives. Lease liabilities are recorded in accrued liabilities and operating lease liabilities, noncurrent. ROU assets are recorded in operating lease right-of-use assets. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. Lease agreements that contain both lease and non-lease components are generally accounted for separately. The Company does not recognize lease liabilities and ROU assets for short-term leases with terms of twelve months or less. Acquisitions and Business Combinations In each acquisition transaction, the Company assesses whether the transaction should follow accounting guidance applicable to an asset acquisition or a business combination. This assessment requires an evaluation of whether the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets, resulting in an asset acquisition or, if not, resulting in a business combination. An asset acquisition is an acquisition of an asset, or a group of assets, that does not meet the definition of a business. The Company accounts for asset acquisitions using the cost accumulation and allocation model, whereby the costs of acquisition are allocated to the assets acquired on a relative fair value basis in accordance with the Company’s accounting policies. The Company accounts for business combinations using the acquisition method, which requires that the total consideration for each of the acquired business be allocated to the assets acquired and liabilities assumed based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair values of these identifiable assets and liabilities is recorded as goodwill. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. In determining the fair value of assets acquired and liabilities assumed in a business combination, the Company used the income approach to value its most significant acquired asset. Significant assumptions relating to the Company’s estimates in the income approach include base revenue, revenue growth rate net of client attrition, projected gross margin, discount rates, projected operating expenses and the future effective income tax rates. The valuations of our acquired businesses have been performed by a third-party valuation specialist under the Company management’s supervision. The Company believes that the estimated fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use. However, such assumptions are inherently uncertain and actual results could differ from those estimates. Future changes in our assumptions or the interrelationship of those assumptions may negatively impact future valuations. In future measurements of fair value, adverse changes in discounted cash flow assumptions could result in an impairment of goodwill or intangible assets that would require a non-cash charge to the consolidated statements of operations and comprehensive loss and may have a material effect on our financial condition and operating results. Acquisition related costs in a business combination are not considered part of the consideration, and are expensed as operating expense as incurred. Contingent consideration, if any, is measured at fair value initially on the acquisition date as well as subsequently at the end of each reporting period until settlement at the end of the assessment period. The Company includes the results of operations of the businesses acquired as of the beginning of the acquisition dates. Goodwill The Company conducts a test for the impairment of goodwill at the reporting unit level on at least an annual basis and whenever there are events or changes in circumstances that would more likely than not reduce the estimated fair value of a reporting unit below its carrying value. Application of the goodwill impairment test requires judgment, including the identification of reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value of each reporting unit. Significant judgments required to estimate the fair value of reporting units include estimating future cash flows and determining appropriate discount rates, growth rates, an appropriate control premium and other assumptions. Changes in these estimates and assumptions could materially affect the determination of fair value for each reporting unit which could trigger impairment. The Company performs its annual goodwill impairment test on April 30 and conducts a qualitative assessment to determine whether it is necessary to perform a quantitative goodwill impairment test. In assessing the qualitative factors, the Company considers the impact of key factors such as changes in the general economic conditions, changes in industry and competitive environment, stock price, actual revenue performance compared to previous years, forecasts and cash flow generation. The Company had one reporting unit for purposes of allocating and testing goodwill for fiscal year 2024. Based on the results of the qualitative assessment completed as of April 30, 2024, there were no indicators of impairment. Long-Lived Assets The Company evaluates long-lived assets, such as property and equipment and purchased intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If necessary, a quantitative test is performed that requires the application of judgment when assessing the fair value of an asset. When the Company identifies an impairment, it reduces the carrying amount of the asset to its estimated fair value based on a discounted cash flow approach or, when available and appropriate, to comparable market values. As of April 30, 2024, the Company evaluated its long-lived assets and concluded there were no indicators of impairment . The weighted-average useful life of intangible assets was 3.8 years as of June 30, 2024. Investments in Equity Securities The Company’s investments in equity securities, which are reported within other assets, noncurrent, on the consolidated balance sheets, include investments in privately held companies without readily determinable market values. The Company adjusts the carrying value of its investments in equity securities to fair value when transactions for identical or similar investments of the same issuer are observable. All gains and losses on investments in equity securities, realized and unrealized, are recognized within other (expense) income, net on the Company’s consolidated statements of operations and comprehensive loss . The Company applies the equity method of accounting for investments in other entities when it exercises significant influence. Under the equity method, the Company’s share of each investee’s profit or loss is recognized within other (expense) income, net on the Company’s consolidated statements of operations and comprehensive loss . The Company applies the fair value measurement alternative for investments in other entities when it holds less than 20 % ownership in the entity and does not exercise significant influence. These investments consist of equity holdings in non-public companies and are recorded within other assets, noncurrent, on the consolidated balance sheets. The Company regularly reviews investments accounted for under the equity method and the fair value measurement alternative for possible impairment, which generally involves an analysis of the facts and changes in circumstances influencing the investment, expectations of the entity’s cash flows and capital needs, and the viability of its business model. The evaluation for impairment of investments in equity securities considers qualitative factors, including the financial condition and specific events related to an investee that may indicate the fair value of the investment is less than its carrying value. For fiscal year 2024, an impairment charge for investments in equity securities of $ 2.0 million was recorded within other (expense) income, net on the consolidated statement of operations and comprehensive loss. Income Taxes The Company accounts for income taxes using an asset and liability approach to record deferred taxes. The Company’s deferred income tax assets represent temporary differences between the financial statement carrying amount and the tax basis of existing assets and liabilities that will result in deductible amounts in future years, including net loss carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets and liabilities are expected to be realized or settled. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized. The Company regularly assesses the realizability of our deferred tax assets. Judgment is required to determine whether a valuation allowance is necessary and the amount of such valuation allowance, if appropriate. The Company considers all available evidence, both positive and negative to determine, based on the weight of available evidence, whether it is more likely than not that some or all of the deferred tax assets will not be realized. In evaluating the need, or continued need, for a valuation allowance the Company considers, among other things, the nature, frequency and severity of current and cumulative taxable income or losses, forecasts of future profitability, and the duration of statutory carryforward periods. The Company’s judgments regarding future profitability may change due to future market conditions, changes in U.S. or international tax laws and other factors. The Company recognizes tax benefits from an uncertain tax position only if it is more likely than not, based on the technical merits of the position, that the tax position will be sustained on examination by the tax authorities. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Interest and penalties related to unrecognized tax benefits are recognized within income tax expense. Foreign Currency Translation The Company’s foreign operations are subject to exchange rate fluctuations. The majority of the Company’s sales and expenses are denominated in U.S. dollars. The functional currency for the majority of the Company’s foreign subsidiaries is the U.S. dollar. For these subsidiaries, assets and liabilities denominated in foreign currency are remeasured into U.S. dollars at current exchange rates for monetary assets and liabilities and historical exchange rates for nonmonetary assets and liabilities. Net revenue, cost of revenue and expenses are generally remeasured at average exchange rates in effect during each period. Gains and losses from foreign currency remeasurement are included in other (expense) income, net in the Company’s consolidated statements of operations and comprehensive loss. Certain foreign subsidiaries designate the local currency as their functional currency. For those subsidiaries, the assets and liabilities are translated into U.S. dollars at exchange rates in effect at the balance sheet date. Income and expense items are translated at average exchange rates for the period. The foreign currency translation adjustments are included in accumulated other comprehensive loss as a separate component of stockholders’ equity. Foreign currency transaction gains and losses are recorded within other (expense) income, net in the Company’s consolidated statements of operations and comprehensive loss and were not material for any period presented. Comprehensive Loss Comprehensive loss consists of net loss and foreign currency translation adjustments from those subsidiaries not using the U.S. dollar as their functional currency. Comprehensive loss is disclosed as part of the statements of operations and comprehensive loss. Loss Contingencies The Company is subject to the possibility of various loss contingencies arising in the ordinary course of business. Management considers the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as its ability to reasonably estimate the amount of loss, in determining loss contingencies. An estimated loss contingency is accrued when it is probable that an asset has been impaired or a liability has been incurred and the amount of loss can be reasonably estimated. The Company regularly evaluates current information available to its management to determine whether such accruals should be adjusted and whether new accruals are required. From time to time, the Company is involved in disputes, litigation and other legal actions. The Company records a charge equal to at least the minimum estimated liability for a loss contingency only when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements, and (ii) the range of loss can be reasonably estimated. The actual liability in any such matters may be materially different from the Company’s estimates, which could result in the need to adjust the liability and record additional expenses. Stock-Based Compensation The Company measures and records the expense related to stock-based transactions based on the fair values of stock-based payment awards, as determined on the date of grant. The fair value of restricted stock units with a service condition (“service-based RSU”) is determined based on the closing price of the Company’s common stock on the date of grant. To estimate the fair value of stock options and purchase rights granted under the employee stock purchase plan (“ESPP”), the Company selected the Black-Scholes option pricing model. The fair value of restricted stock units with a service and performance condition (“performance-based RSU”) is determined based on the closing price of the Company’s common stock on the date of grant. Grant date as defined by ASC 718 is determined when the components that comprise the performance targets have been fully established. If a grant date has not been established, the compensation expense associated with the performance-based RSUs is re-measured at each reporting date based on the closing price of the Company’s common stock at each reporting date until the grant date has been established. In applying these models, the Company’s determination of the fair value of the award is affected by assumptions regarding a number of subjective variables. These variables include, but are not limited to, the Company’s expected stock price volatility over the term of the award and the employees’ actual and projected stock option exercise and pre-vesting employment termination behaviors. The Company recognizes stock-based compensation expense for options and service-based RSUs using the straight-line method, and for performance-based RSUs using the graded vesting method, based on awards ultimately expected to vest. The Company recognizes stock-based compensation expense for the purchase rights granted under the ESPP using the straight-line method over the offering period. The Company estimates future forfeitures at the date of grant. On an annual basis, the Company assesses changes to its estimate of expected forfeitures based on recent forfeiture activity. The effect of adjustments made to the forfeiture rates, if any, is recognized in the period that change is made. See Note 13, Stock Benefit Plans , for additional information regarding stock-based compensation. 401(k) Savings Plan The Company sponsors a 401(k) defined contribution plan covering all U.S. employees. There were no employer contributions under this plan in fiscal years 2024 and 2023. Recent Accounting Pronouncements Accounting Pronouncements Already Adopted In October 2021, the Financial Standards Accounting Board (FASB) issued Accounting Standards Update (ASU) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (ASU 2021-08), which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers , as if the acquirer had originated the contracts. The Company adopted ASU 2021-08 in the first quarter of fiscal year 2024 on a prospective basis. The adoption of this ASU did not have a material impact on the Company's financial statements. Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ( ASU 2023-07) which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal periods beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. The Company is currently evaluating the impact of this ASU on its financial statement disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topics 740): Improvements to Income Tax Disclosures (ASU 2023-09) to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its financial statement disclosures. ASU’s not included in the Company's disclosures were assessed and determined to be not applicable and material to the Company’s consolidated financial statements or disclosures. |
Revenue
Revenue | 12 Months Ended |
Jun. 30, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | 3. Revenue Disaggregation of Revenue The following table presents the Company’s net revenue disaggregated by vertical (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Net revenue: Financial Services $ 392,579 $ 379,723 $ 417,110 Home Services 211,944 193,133 158,805 Other Revenue 8,991 7,768 6,184 Total net revenue $ 613,514 $ 580,624 $ 582,099 Contract Balances The following table provides information about contract liabilities from the Company’s contracts with its clients (in thousands): June 30, 2024 2023 Client deposits $ 1,344 $ 1,213 Deferred revenue — 9 Total $ 1,344 $ 1,222 The Company’s contract liabilities result from payments received in advance of revenue recognition and advance consideration received from clients, which precede the Company’s satisfaction of the associated performance obligation. The changes in the liability balances during fiscal year 2024 related to advance consideration received from clients of $ 18.7 million, offset by revenue recognized of $ 18.5 million. |
Net Loss per Share
Net Loss per Share | 12 Months Ended |
Jun. 30, 2024 | |
Earnings Per Share [Abstract] | |
Net Loss per Share | 4. Net Loss per Share Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by using the weighted-average number of shares of common stock outstanding, including potential dilutive shares of common stock assuming the dilutive effect of outstanding stock options, unvested restricted stock units, and shares issuable related to the ESPP using the treasury stock method. The following table presents the calculation of basic and diluted net loss per share: Fiscal Year Ended June 30, 2024 2023 2022 (In thousands, except per share data) Numerator: Net loss $ ( 31,331 ) $ ( 68,866 ) $ ( 5,248 ) Denominator: Weighted average shares of common stock used in computing 54,917 53,799 54,339 Weighted average effect of dilutive securities — — — Weighted average shares of common stock used in computing diluted net loss per share 54,917 53,799 54,339 Net loss per share: Basic and diluted (1) $ ( 0.57 ) $ ( 1.28 ) $ ( 0.10 ) Securities excluded from weighted average shares of common stock used in computing diluted net loss per share because the effect would have been anti-dilutive: (2) 4,453 4,247 3,557 (1) Diluted net loss per share does not reflect any potential common stock relating to stock options, restricted stock units, or shares issuable related to the ESPP due to net loss incurred in fiscal years 2024, 2023 and 2022. The assumed issuance of any additional shares would be anti-dilutive. (2) These weighted shares relate to anti-dilutive stock options, restricted stock units, and shares issuable related to the ESPP as calculated using the treasury stock method and could be dilutive in the future . |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Jun. 30, 2024 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | 5. Fair Value Measurements The following table presents the fair value of the Company’s financial instruments (in thousands): June 30, 2024 June 30, 2023 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets: Money market funds $ 2,215 $ — $ — $ 2,215 $ 16,910 $ — $ — $ 16,910 Liabilities: Post-closing payments related to acquisitions $ — $ 18,143 $ — $ 18,143 $ — $ 17,498 $ — $ 17,498 Contingent consideration related to acquisitions — — 2,466 2,466 — — 1,039 1,039 Total $ — $ 18,143 $ 2,466 $ 20,609 $ — $ 17,498 $ 1,039 $ 18,537 Reported as: Cash and cash equivalents $ 2,215 $ 16,910 Other Liabilities: Current $ 9,372 $ 7,875 Noncurrent 11,237 10,662 Total $ 20,609 $ 18,537 There were no transfers between Level 1, Level 2 and Level 3 during the periods presented. Cash Equivalents The valuation technique used to measure the fair value of money market funds included using quoted prices in active markets for identical assets. Post-Closing Payments Related to Acquisitions The post-closing payments are future payments related to the acquisitions of BestCompany.com, LLC (“BestCompany”) and Aqua Vida, LLC (“AquaVida”) in fiscal year 2024, and Modernize, Inc. (“Modernize”) in fiscal year 2021. As the fair value of the Company’s post-closing payments was determined based on installments stipulated in the terms of the acquisition agreements and discount rates observable in the market, the post-closing payments are classified as Level 2 within the fair value hierarchy. See Note 6, Acquisitions , for further details related to the acquisitions. Contingent Consideration Related to Acquisitions The contingent consideration consists of the estimated fair value of future payments related to the Company’s acquisitions of AquaVida and CCM. The AquaVida contingent consideration is based upon margin targets, and the CCM contingent consideration is based upon revenue targets. The fair value of the contingent consideration is determined using the real options technique which incorporates various estimates, including projected net revenue, projected gross margin, volatility and discount rates. As certain of these inputs are not observable in the market, the contingent consideration is classified as a Level 3 instrument. Significant changes in the projected net revenue, projected gross margin, or discount rates would have a material impact on the fair value of the contingent consideration. Changes in the fair value of the contingent consideration are recorded in earnings on the Company’s consolidated statements of operations and comprehensive loss. See Note 6, Acquisitions , for further details related to the acquisitions. The Company reassesses the estimated fair value of the contingent consideration at the end of each reporting period based on the information available at the time. There was no adjustment for change in fair value recorded for the contingent consideration in fiscal years 2024 and 2023 based on the information and evidence available as of each period end. The following table presents the changes in the contingent consideration (in thousands): Level 3 Balance at June 30, 2022 $ 1,787 Payments made during the period ( 748 ) Balance at June 30, 2023 1,039 Additions related to the acquisition of AquaVida (initial measurement) 2,100 Payments made during the period ( 673 ) Balance at June 30, 2024 $ 2,466 |
Acquisitions
Acquisitions | 12 Months Ended |
Jun. 30, 2024 | |
Business Combinations [Abstract] | |
Acquisitions | 6. Acquisitions BestCompany On January 4, 2024 , the Company acquired certain assets of BestCompany, a leading performance-based marketing company specializing in purchasing media traffic data from third party platforms and generating qualified inquiries from such data, to broaden the Company's customer and media relationships in the home services vertical. In exchange for certain assets of BestCompany, the Company paid $ 2.5 million in cash upon closing and will make $ 4.0 million in post-closing payments, payable in equal annual installments over two years , with the first installment payable twelve months following the date of closing. The purchase consideration also includes an incremental $ 1.0 million to BestCompany in the form of a two-year convertible promissory note. The following table summarizes the consideration as of the acquisition date (in thousands): Estimated Fair Value Cash $ 2,510 Post-closing payments, net of imputed interest of $ 325 3,696 Promissory note adjustment 158 Total $ 6,364 The Company evaluated the set of activities and assets acquired and concluded that it did not meet the definition of a business because the acquired set did not include a substantive process. Therefore, the acquisition was accounted for as an asset acquisition and the total purchase price was allocated to the acquired assets. The results of the acquired assets have been included in the Company's results of operations since the acquisition date. The Company measured assets acquired using a cost accumulation and allocation model under which cost of the acquisition is allocated to the assets acquired. The fair value of the intangible assets acquired was determined by the Company based on management’s best estimates, and in doing so management engaged a third-party valuation specialist to assist with the measurement. The fair value of the shared assets license was determined using the multi-period excess earnings income approach. The fair value of the customer relationships was determined using the distributor method. The fair value of the non-competition agreements was determined using the with and without method. The excess of the purchase price over the aggregate fair value of the identifiable intangible assets acquired was allocated to the individual assets acquired based on their relative fair values. No goodwill is recognized. The following table summarizes the components and allocation of the purchase price, the fair values and estimated useful lives of the identifiable assets acquired as of the date of the acquisition (in thousands): Estimated Estimated Shared assets license $ 5,228 10 years Client relationships 682 8 years Non-competition agreements 454 3 years Total $ 6,364 Aqua Vida On March 1, 2024 , the Company acquired certain assets of AquaVida, a performance-based marketing company specializing in media generation, to broaden the Company's access to large and meaningful media channels in all verticals. In exchange for the assets of AquaVida, the Company paid $ 2.0 million in cash upon closing and will make $ 4.0 million in post-closing payments, payable in equal annual installments over a four-year period, with the first installment payable twelve months following the date of closing. The purchase consideration also includes a contingent consideration based on future media margin results, payable for four years following the date of closing. The following table summarizes the consideration as of the acquisition date (in thousands): Estimated Fair Value Cash $ 2,000 Post-closing payments, net of imputed interest of $ 535 3,465 Contingent consideration 2,100 Total $ 7,565 The acquisition was accounted for as a business combination. The results of the acquired assets have been included in the Company's results of operations since the acquisition date. The Company allocated the purchase price to identifiable intangible assets acquired based on their estimated fair values. The fair value of the intangible assets acquired was determined by the Company based on management’s best estimates, and in doing so management engaged a third-party valuation specialist to assist with the measurement. The fair value of the existing technology was determined using the multi-period excess earnings income approach. The fair value of the customer relationships was determined using the distributor approach. The fair value of content was determined using the replacement cost method. The fair value of the non-competition agreement was determined using with and without method. The excess of the purchase price over the aggregate fair value of the identifiable intangible assets acquired was recorded as goodwill and is primarily attributable to synergies the Company expects to achieve related to the acquisition. The goodwill is deductible for tax purposes. The following table summarizes the components and preliminary allocation of the purchase price, the fair values and estimated useful lives of the identifiable assets acquired as of the date of the acquisition (in thousands): Estimated Estimated Existing technology $ 1,900 5 years Client relationships 1,200 8 years Content 50 1 year Non-competition agreement 500 4 years Goodwill 3,915 Indefinite Total $ 7,565 The Company is still finalizing the allocation of the purchase price to the individual assets acquired. Accordingly, these preliminary estimates are subject to change during the measurement period, which is the period subsequent to the acquisition date during which the acquirer may adjust the provisional amounts recognized for a business combination, not to exceed one year from the acquisition date. The final purchase price allocation, which may include changes in the allocations within intangible assets and between intangible assets and goodwill, as well as changes in the estimated useful lives of the intangible assets, will be determined when the Company has completed the detailed review of underlying inputs and assumptions used in its preliminary purchase price allocation. Other In fiscal year 2022 , the Company completed two immaterial acquisitions within the home services client vertical. The purchase consideration included $ 1.0 million for each of the acquisition in cash upon closing. The purchase consideration also included a $ 2.0 million post-closing payments, payable in equal annual installments over a two-year period, with the first installment paid in the second quarter of fiscal year 2023 , and a $ 1.0 million post-closing payments, payable in equal annual installments over a two-year period, with the first installment paid in the fourth quarter of fiscal year 2023 . The results of these acquisitions have been included in the Company’s results of operations since their respective acquisition dates, which were not considered material to the Company. |
Balance Sheet Components
Balance Sheet Components | 12 Months Ended |
Jun. 30, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Balance Sheet Components | 7. Balance Sheet Components Accounts Receivable, Net Accounts receivable, net was comprised of the following (in thousands): June 30, 2024 2023 Accounts receivable, gross $ 113,892 $ 71,470 Less: Allowance for credit losses and revenue reserves ( 2,106 ) ( 3,722 ) Total accounts receivable, net $ 111,786 $ 67,748 Prepaid Expenses and Other Assets Prepaid expenses and other assets were comprised of the following (in thousands): June 30, 2024 2023 Prepaid expenses $ 6,217 $ 8,241 Income tax receivable 63 120 Other assets 533 1,418 Total prepaid expenses and other assets $ 6,813 $ 9,779 Property and Equipment, Net Property and equipment, net was comprised of the following (in thousands): June 30, 2024 2023 Computer equipment $ 13,259 $ 12,236 Software 1,262 825 Furniture and fixtures 375 346 Leasehold improvements 3,889 1,377 Internal software development costs 29,474 18,568 Property and equipment, gross 48,259 33,352 Less: Accumulated depreciation and amortization ( 28,401 ) ( 16,603 ) Total property and equipment, net $ 19,858 $ 16,749 Depreciation expense was $ 3.0 million, $ 2.8 million and $ 2.4 million for fiscal years 2024, 2023 and 2022. Amortization expense related to internal software development costs was $ 10.2 million, $ 5.3 million and $ 3.0 million for fiscal years 2024, 2023 and 2022. Accrued liabilities Accrued liabilities were comprised of the following (in thousands): June 30, 2024 2023 Accrued media costs $ 52,805 $ 27,302 Accrued compensation and related expenses 6,579 7,812 Accrued professional service and other business expenses 6,348 5,579 Operating lease liabilities, current 3,090 3,317 Deferred revenue (1) — 9 Total accrued liabilities $ 68,822 $ 44,019 (1) Accrued liabilities include deferred revenue of $ 9 thousand as of June 30, 2023, which previously has been presented as a separate component in the balance sheets. Other liabilities, noncurrent Other liabilities, noncurrent were comprised of the following (in thousands): June 30, 2024 2023 Post-closing payments and contingent consideration related to acquisitions $ 11,237 $ 10,662 Income tax liabilities 6,089 5,493 Other liabilities 118 118 Total other liabilities, noncurrent $ 17,444 $ 16,273 |
Intangible Assets, Net and Good
Intangible Assets, Net and Goodwill | 12 Months Ended |
Jun. 30, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets, Net and Goodwill | 8. Intangible Assets, Net and Goodwill Intangible Assets, Net Intangible assets, net consisted of the following (in thousands): June 30, 2024 June 30, 2023 Gross Net Gross Net Carrying Accumulated Carrying Carrying Accumulated Carrying Amount Amortization Amount Amount Amortization Amount Customer/publisher/advertiser relationships $ 93,511 $ ( 68,770 ) $ 24,741 $ 91,629 $ ( 61,025 ) $ 30,604 Content 43,106 ( 43,068 ) 38 43,056 ( 43,056 ) — Website/trade/domain names 25,422 ( 20,051 ) 5,371 25,422 ( 19,451 ) 5,971 Acquired technology and others 43,014 ( 35,156 ) 7,858 34,934 ( 32,809 ) 2,125 Total $ 205,053 $ ( 167,045 ) $ 38,008 $ 195,041 $ ( 156,341 ) $ 38,700 Amortization of intangible assets was $ 10.7 million, $ 11.1 million and $ 11.6 million for fiscal years 2024, 2023 and 2022. Future amortization expense for the Company’s intangible assets as of June 30, 2024 was as follows (in thousands): Fiscal Year Ending June 30, Amortization 2025 $ 9,533 2026 6,887 2027 5,864 2028 5,281 2029 4,234 Thereafter 6,209 Total $ 38,008 Goodwill The addition to goodwill during fiscal year 2024 was associated the acquisition of AquaVida. There was no addition to goodwill during fiscal year 2023. See Note 6, Acquisitions, for further details related to the acquisitions. There was no goodwill impairment recognized during fiscal years 2024 and 2023. The changes in the carrying amount of goodwill were as follows (in thousands): Goodwill Balance at June 30, 2023 $ 121,141 Addition related to the acquisition of AquaVida 3,915 Balance at June 30, 2024 $ 125,056 |
Income Taxes
Income Taxes | 12 Months Ended |
Jun. 30, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 9. Income Taxes The components of loss before income taxes were as follows (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 US $ ( 31,110 ) $ ( 21,745 ) $ ( 6,022 ) Foreign 714 383 260 Total $ ( 30,396 ) $ ( 21,362 ) $ ( 5,762 ) The components of the provision for (benefit from) income taxes were as follows (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Current: Federal $ — $ — $ — State 125 143 176 Foreign 305 224 195 Total current provision for income taxes 430 367 371 Deferred: Federal 572 40,780 ( 1,032 ) State ( 104 ) 6,357 147 Foreign 37 — — Total deferred provision for (benefit from) income taxes 505 47,137 ( 885 ) Total provision for (benefit from) income taxes $ 935 $ 47,504 $ ( 514 ) The reconciliation between the statutory federal income tax expense and the Company’s effective income tax expense (benefit) was as follows (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Statutory federal income tax expense $ ( 6,359 ) $ ( 4,486 ) $ ( 1,210 ) States taxes, net of federal benefit ( 1,553 ) ( 752 ) ( 314 ) Foreign rate differential 106 61 11 Stock-based compensation expense (benefit) 25 676 ( 774 ) Change in valuation allowance 8,113 52,396 ( 1,034 ) Research and development credits ( 1,593 ) ( 1,847 ) ( 1,174 ) Disqualified compensation expense 1,363 744 1,806 Uncertain tax position 490 550 385 Expired attributes 188 273 261 Foreign deferred adjustment ( 6 ) — 1,354 Other 161 ( 111 ) 175 Effective income tax expense (benefit) $ 935 $ 47,504 $ ( 514 ) The components of the noncurrent deferred tax assets and liabilities, net were as follows (in thousands): June 30, 2024 2023 Noncurrent deferred tax assets: Reserves and accruals $ 1,192 $ 1,716 Stock-based compensation expense 3,340 3,099 Net operating loss 38,590 35,430 Fixed assets 330 246 Tax credits 15,496 13,790 Operating lease liabilities 2,583 960 Research and development capitalized cost 12,985 7,221 Other 623 198 Total noncurrent deferred tax assets 75,139 62,660 Less: valuation allowance — long-term ( 67,669 ) ( 59,556 ) Total noncurrent deferred tax assets, net of valuation allowance 7,470 3,104 Noncurrent deferred tax liabilities: Intangibles ( 8,434 ) ( 5,303 ) Operating lease right-of-use assets ( 2,458 ) ( 718 ) Total noncurrent deferred tax liabilities ( 10,892 ) ( 6,021 ) Net deferred tax liabilities $ ( 3,422 ) $ ( 2,917 ) The Company has a net deferred tax liability balance of $ 3.4 million and $ 2.9 million as of June 30, 2024 and 2023, included within other liabilities, noncurrent on the Company’s consolidated balance sheet. The net deferred tax liability is related to indefinite lived deferred tax liabilities unable to be offset with deferred tax assets. The Company has a valuation allowance of approximately $ 67.7 million and $ 59.6 million as of June 30, 2024 and 2023, respectively. The Company evaluated the need for a valuation allowance by considering among other things, the nature, frequency and severity of current and cumulative losses, reversal of taxable temporary differences, tax planning strategies, forecasts of future profitability, and the duration of statutory carryforward periods. The Company determined that the significant negative evidence associated with cumulative losses in recent periods and current results outweighed the positive evidence as of June 30, 2024 and accordingly, the near-term realization of certain of these assets was deemed not more likely than not. In the fourth quarter of fiscal year 2023, the Company recorded a one-time, non-cash charge to income tax expense of $ 52.4 million to establish a valuation allowance against its net deferred tax assets. The Company will continue to assess the likelihood that the deferred tax assets will be realizable at each reporting period and the valuation allowance will be adjusted accordingly. As of June 30, 2024 and 2023, the Company had a federal operating loss carryforward of approximately $ 152.9 million and $ 141.5 million. As of June 30, 2024 and 2023, the Company’s state operating loss carryforward was approximately $ 97.6 million and $ 83.8 million. With the exception of $ 69.5 million of federal net operating losses which can be carried forward indefinitely, the federal and state net operating losses, if not used, will begin to expire on June 30, 2035 and June 30, 2025 , respectively. The operating loss carryforward in the India jurisdiction was approximately $ 1.8 million which will begin to expire on June 30, 2025 . The Company has federal and California research and development tax credit carryforwards of approximately $ 10.8 million and $ 12.2 million to offset future taxable income. The federal research and development tax credits, if not used, will begin to expire on June 30, 2034 , while the state tax credit carryforwards do not have an expiration date and may be carried forward indefinitely. Utilization of the operating loss carryforwards and credits may be subject to a substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitation may result in the expiration of operating loss carryforwards and credits before utilization. A reconciliation of the beginning and ending amounts of unrecognized tax benefits was as follows (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Balance at beginning of the year $ 6,030 $ 5,296 $ 4,756 Gross increases - current period tax positions 654 717 542 Gross decreases - prior period tax positions ( 40 ) — — Gross increases - prior period tax positions — 19 — Reductions as a result of lapsed statute of limitations — ( 2 ) ( 2 ) Balance at end of the year $ 6,644 $ 6,030 $ 5,296 The Company’s policy is to include interest and penalties related to unrecognized tax benefits within the Company’s provision for (benefit from) income taxes. As of June 30, 2024, the Company has accrued $ 1.6 million for interest and penalties related to the unrecognized tax benefits. The balance of interest and penalties is recorded as other liabilities, noncurrent on the Company’s consolidated balance sheet. As of June 30, 2024, unrecognized tax benefits of $ 1.1 million, if recognized, would affect the Company’s effective tax rate. The Company does not anticipate that the amount of existing unrecognized tax benefits will significantly increase or decrease within the next 12 months. The Company files income tax returns in the United States, various U.S. states and certain foreign jurisdictions and is no longer subject to U.S. federal, state and local, or non-U.S., income tax examinations by tax authorities for years before 2013. As of June 30, 2024, the tax years 2013 through 2024 remain open in the U.S., and the tax years 2020 through 2024 remain open in various foreign jurisdictions. The Company believes that adequate amounts have been reserved for any adjustments that may ultimately result from our examinations. |
Leases
Leases | 12 Months Ended |
Jun. 30, 2024 | |
Leases [Abstract] | |
Leases | 10 . Leases The Company has operating leases primarily for its office facilities. The leases expire at various dates through fiscal year 2030, some of which include options to renew, with renewal terms of up to 5 years . T he Company does not include any renewal options in the lease terms for calculating lease liability, as the renewal options allow the Company to maintain operational flexibility and the Company is not reasonably certain that it will exercise these renewal options at the time of the lease commencement. The components of lease expense were as follows (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Operating lease expense $ 4,220 $ 4,790 $ 5,172 Short-term lease expense 840 638 619 Variable lease expense (1) 565 666 676 Total lease expense $ 5,625 $ 6,094 $ 6,467 (1) Variable lease expense is primarily composed of common area maintenance charges. Supplemental information related to operating leases was as follows (in thousands, except lease term and discount rate): Fiscal Year Ended June 30, 2024 2023 2022 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows used for operating leases $ 5,114 $ 5,860 $ 6,206 Lease liabilities arising from obtaining right-of-use assets Operating leases $ 11,026 $ 824 $ 564 Weighted average remaining lease term - operating leases 4.3 years 1.5 years 1.9 years Weighted average discount rate - operating leases 6.9 % 5.5 % 5.1 % The implicit rate within each lease is not readily determinable and therefore the Company uses its incremental borrowing rate at the lease commencement date to determine the present value of the lease payments. The determination of the incremental borrowing rate requires judgment. The Company determined its incremental borrowing rate for each lease using indicative bank borrowing rates, adjusted for various factors including level of collateralization, term and currency to align with the terms of a lease. Maturities of operating lease liabilities as of June 30, 2024 were as follows (in thousands): Fiscal Year Ending June 30, Amount 2025 $ 3,511 2026 2,881 2027 2,750 2028 2,728 2029 1,457 Thereafter 209 Total minimum lease payments 13,536 Less: imputed interest ( 2,567 ) Present value of net minimum lease payments $ 10,969 Operating lease liabilities: Current (included in Accrued Liabilities) $ 3,090 Noncurrent 7,879 Total $ 10,969 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Jun. 30, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 11. Commitments and Contingencies Guarantor Arrangements The Company has agreements whereby it indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was, serving at the Company’s request in such capacity. The term of the indemnification period is for the officer or director’s lifetime. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has a director and officer insurance policy that limits its exposure and enables the Company to recover a portion of any future amounts under certain circumstances and subject to deductibles and exclusions. As a result of its insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is not material. Accordingly, the Company had no liabilities recorded for these agreements as of June 30, 2024 and 2023. In the ordinary course of its business, the Company from time to time enters into standard indemnification provisions in its agreements with its clients. Pursuant to these provisions, the Company may be obligated to indemnify its clients for certain losses suffered or incurred, including losses arising from violations of applicable law by the Company or by its third-party publishers, losses arising from actions or omissions of the Company or its third-party publishers, and for third-party claims that a Company product infringed upon any United States patent, copyright, or other intellectual property rights. Where practicable, the Company limits its liabilities under such indemnities. Subject to these limitations, the term of such indemnification provisions is generally coterminous with the corresponding agreements and survives for the duration of the applicable statute of limitations after termination of the agreement. The potential amount of future payments to defend lawsuits or settle indemnified claims under these indemnification provisions is generally limited and the Company believes the estimated fair value of these indemnity provisions is not material. Accordingly, the Company had no liabilities recorded for these agreements as of June 30, 2024 and 2023. Letters of Credit The Company has a $ 0.3 million letter of credit agreement with a financial institution that is used as collateral for the Company’s corporate headquarters’ operating lease. The letter of credit automatically renews annually without amendment unless canceled by the financial institution within 30 days of the annual expiration date. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Jun. 30, 2024 | |
Equity [Abstract] | |
Stockholders' Equity | 12. Stockholders’ Equity Stock Repurchases In April 2022, the Board of Directors canceled the prior stock repurchase program that commenced in July 2017 and authorized a stock repurchase program allowing the repurchase of up to $ 40.0 million worth of common stock . In fiscal year 2024, the Company repurchased 247,618 shares of its common stock at an average price of $ 8.85 per share, at a total cost of $ 2.2 million (including a broker commission of $ 0.03 per share). In fiscal year 2023, the Company repurchased 403,193 shares of its common stock at an average price of $ 10.02 per share, at a total cost of $ 4.1 million (including a broker commission of $ 0.03 per share). Repurchases under this program took place in the open market and were made under a Rule 10b5-1 plan. The repurchased shares of common stock were recorded as treasury stock and were accounted for under the cost method. As of June 30, 2024, approximately $ 16.8 million remained available for stock repurchases pursuant to the board authorization. Retirement of Treasury Stock In fiscal year 2024, the Company retired 247,618 shares of its common stock with a carrying value of $ 2.2 million . In fiscal year 2023, the Company retired 403,193 shares of its common stock with a carrying value of $ 4.1 million (including 10,000 shares for $ 0.1 million that were repurchased but not settled as of June 30, 2023). The Company’s accounting policy upon the r etirement of treasury stock is to deduct its par value from common stock and reduce additional paid-in capital by the amount recorded in additional paid-in capital when the stock was originally issued. |
Stock Benefit Plans
Stock Benefit Plans | 12 Months Ended |
Jun. 30, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Stock Benefit Plans | 13. Stock Benefit Plans Stock-Based Compensation In fiscal years 2024, 2023 and 2022, the Company recorded stock-based compensation expense of $ 23.7 million, $ 18.8 million and $ 18.5 million. There was no tax benefits realized in fiscal years 2024 and 2023 due to the Company's full valuation allowance. In fiscal year 2022, the Company recognized tax benefits related to stock-based compensation of $ 0.8 million, which are reflected in the Company’s (provision for) benefit from income taxes. Stock Incentive Plans In November 2009, the Company’s board of directors adopted the 2010 Equity Incentive Plan (the “2010 Incentive Plan”) and the Company’s stockholders approved the 2010 Incentive Plan in January 2010. The 2010 Incentive Plan became effective upon the completion of the IPO of the Company’s common stock in February 2010. The 2010 Incentive Plan provides for the grant of incentive stock options (“ISOs”), nonstatutory stock options (“NQSOs”), restricted stock, restricted stock units (“RSUs”), stock appreciation rights, performance-based stock awards and other forms of equity compensation, as well as for the grant of performance cash awards. The Company may issue ISOs only to its employees. NQSOs and all other awards may be granted to employees, including officers, nonemployee directors and consultants. To date, the Company has granted ISOs, NQSOs, service-based RSUs, market-based RSUs, and performance-based RSUs under the 2010 Incentive Plan. ISOs and NQSOs are generally granted to employees with an exercise price equal to the market price of the Company’s common stock at the date of grant. Stock options granted to employees generally have a contractual term of seven years and vest over four years of continuous service, with 25 percent of the stock options vesting on the one-year anniversary of the date of grant and the remaining 75 percent vesting in equal monthly installments over the three year period thereafter. RSUs generally vest over four years of continuous service, with 25 percent of the RSUs vesting on the one-year anniversary of the date of grant and 6.25 percent vesting quarterly thereafter for the next 12 quarters, subject to any performance or stock price targets. Performance-based RSUs vest variably subject to the achievement of performance targets, consisting of both revenue growth and adjusted EBITDA targets. The Company evaluates the portion of the awards that are probable to vest quarterly until the performance criteria are met. An aggregate of 23,125,612 s hares of the Company’s common stock were reserved for issuance under the 2010 Incentive Plan as of June 30, 2024, and this amount will be increased by any outstanding stock awards that expire or terminate for any reason prior to their exercise or settlement. The number of shares of the Company’s common stock reserved for issuance was increased annually through July 1, 2019 by up to five percent of the total number of shares of the Company’s common stock outstanding on the last day of the preceding fiscal year. The maximum number of shares that may be issued under the 2010 Incentive Plan is 30,000,000 . There were 9,396,038 shares available for issuance under the 2010 Incentive Plan as of June 30, 2024. In November 2009, the Company’s board of directors adopted the 2010 Non-Employee Directors’ Stock Award Plan (the “Directors’ Plan”) and the stockholders approved the Directors’ Plan in January 2010. The Directors’ Plan became effective upon the completion of the Company’s IPO. The Directors’ Plan provides for the automatic grant of NQSOs and RSUs to non-employee directors and also provides for the discretionary grant of NQSOs and RSUs. Stock options granted to new non-employee directors vest in equal monthly installments over four years and annual stock option grants to existing directors vest in equal monthly installments over one year . The initial service-based RSU grants vest daily over a period of four years and annual service-based RSU grants vest daily over a period of one year . An aggregate of 4,598,838 shares of the Company’s common stock were reserved for issuance under the Directors’ Plan as of June 30, 2024. This amount was increased annually through July 1, 2019 , by the sum of 200,000 shares and the aggregate number of shares of the Company’s common stock subject to awards granted under the Directors’ Plan during the immediately preceding fiscal year. There were 1,921,954 shares available for issuance under the Directors’ Plan as of June 30, 2024. Valuation Assumptions The Company uses the Black-Scholes option-pricing model to fair value its stock options. Options are granted with an exercise price equal to the fair value of the common stock at the date of grant. The Company calculates the weighted-average expected life of options using the simplified method pursuant to the accounting guidance for share-based payments as its historical exercise experience does not provide a reasonable basis upon which to estimate expected term. The Company estimates the expected volatility of its common stock based on its historical volatility over the expected term of the stock option. The Company has no history or expectation of paying dividends on its common stock. The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected term of the stock option. The weighted-average Black-Scholes model assumptions and the weighted-average grant date fair value of stock options were as follows: Fiscal Year Ended June 30, 2024 2023 2022 Expected term (in years) 3.5 3.5 4.4 Expected volatility 52 % 55 % 58 % Expected dividend yield — — — Risk-free interest rate 4.6 % 3.8 % 1.0 % Grant date fair value $ 5.30 $ 4.85 $ 8.12 Stock Option Award Activity The following table summarizes the stock option award activity under the plans: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding at June 30, 2022 547,619 $ 8.33 2.76 $ 2,110 Granted 11,306 11.18 Exercised ( 109,359 ) 5.37 Forfeited ( 2,439 ) 13.76 Expired ( 3,077 ) 10.49 Outstanding at June 30, 2023 444,050 $ 9.10 2.28 $ 1,283 Granted 9,808 12.54 Exercised ( 217,926 ) 4.21 Forfeited ( 15 ) 15.45 Expired ( 7,314 ) 7.78 Outstanding at June 30, 2024 228,603 $ 13.95 3.23 $ 912 Vested and expected-to-vest at June 30, 2024 (1) 227,879 $ 13.94 3.23 $ 912 Vested and exercisable at June 30, 2024 203,602 $ 13.33 3.15 $ 907 (1) The expected-to-vest options are the result of applying the pre-vesting forfeiture assumption to total outstanding options . The following table summarizes the total intrinsic value, the cash received and the actual tax benefit of options exercised (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Intrinsic value $ 1,561 $ 693 $ 4,262 Cash received 918 587 1,850 Tax benefit — — 725 As of June 30, 2024, there was $ 0.2 million of total unrecognized compensation expense related to unvested stock options which are expected to be recognized over a weighted-average period of 0.9 year. Service-Based Restricted Stock Unit Activity The following table summarizes the service-based RSU activity under the plans: Shares Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding at June 30, 2022 1,890,481 $ 14.33 1.32 $ 19,018 Granted 1,896,618 11.06 Vested ( 778,233 ) 15.42 Forfeited ( 109,707 ) 13.18 Outstanding at June 30, 2023 2,899,159 $ 11.95 1.30 $ 25,600 Granted 1,887,379 9.68 Vested ( 1,222,938 ) 12.32 Forfeited ( 141,733 ) 11.24 Outstanding at June 30, 2024 3,421,867 $ 10.59 1.26 $ 56,769 As of June 30, 2024, there was $ 26.0 million of total unrecognized compensation expense related to service-based RSUs. Performance-Based Restricted Stock Unit Activity The following table summarizes the performance-based RSU activity under the 2010 Incentive Plan: Shares Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding at June 30, 2022 1,223,977 $ 13.32 1.12 $ 12,313 Granted 308,000 8.83 Vested ( 504,086 ) 13.44 Forfeited ( 149,420 ) 13.47 Outstanding at June 30, 2023 878,471 $ 11.66 1.05 $ 7,757 Granted 616,000 16.59 Vested ( 291,628 ) 14.47 Forfeited ( 186,158 ) 9.48 Outstanding at June 30, 2024 1,016,685 $ 14.24 1.12 $ 16,867 As of June 30, 2024, there was $ 4.7 million of total unrecognized compensation expense related to performance-based RSUs. At the time of vesting, a portion of RSUs are withheld by the Company to provide for federal and state tax withholding obligations resulting from the release of the RSUs. Employee Stock Purchase Plan In October 2021, the Company adopted the 2021 Employee Stock Purchase Plan (the “2021 ESPP”), with 2,164,999 shares of common stock reserved for future issuance under the plan. The 2021 ESPP allows eligible employees to purchase shares of the Company’s common stock at a discount through payroll deductions of up to 15 % of their eligible compensation. The 2021 ESPP provides for consecutive offering periods that will typically have a duration of approximately 24 months in length, and each offering period is comprised of four purchase periods of approximately six months in length. On each purchase date, eligible employees may purchase the Company’s common stock at a price per share equal to 85 % of the lesser of (1) the fair market value of the common stock on the first trading day of each offering period, or (2) the fair market value of the common stock on the purchase date. A participant may purchase up to a maximum of 2,500 shares of the common stock during each purchase period, subject to a maximum of $ 25,000 worth of shares of the common stock in each calendar year (as determined under applicable tax rules). If the fair market value of the common stock on any purchase date is lower than it was on the first trading day of that offering period, participants will be automatically withdrawn from the current offering period and be immediately re-enrolled in a new offering period. In fiscal year 2024, 317,394 shares of common stock were purchased under the 2021 ESPP. As of June 30, 2024, 1,568,959 shares were available for issuance under the 2021 ESPP. ESPP employee payroll contributions accrued as of June 30, 2024 amounting to $ 1.2 million are included within accrued liabilities on the Company’s consolidated balance sheet, and will be used to purchase shares at the ESPP purchase period ending on August 24, 2024 . The fair value of the purchase rights for the ESPP are estimated on the date of grant using the Black-Scholes model with the following assumptions: Fiscal Year Ended June 30, 2024 2023 2022 Expected term (in years) 0.5 - 2.0 0.5 - 2.0 0.5 - 2.0 Expected volatility 48 % - 58 % 48 % - 57 % 48 % - 64 % Expected dividend yield — — — Risk-free interest rate 4.5 % - 5.5 % 2.9 % - 5.0 % 0.3 % - 1.0 % Grant date fair value $ 2.97 - $ 6.73 $ 3.77 - $ 8.11 $ 3.72 - $ 5.33 |
Segment Information
Segment Information | 12 Months Ended |
Jun. 30, 2024 | |
Segment Reporting [Abstract] | |
Segment Information | 14. Segment Information Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker, its chief executive officer, reviews financial information presented on a consolidated basis, and no expense or operating income is evaluated at a segment level. Given the consolidated level of review by the Company’s chief executive officer, the Company operates as one reportable segment. The following tables summarize the net revenue and long-lived assets by geographic area (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Net revenue: United States $ 607,373 $ 570,703 $ 559,984 International 6,141 9,921 22,115 Total net revenue $ 613,514 $ 580,624 $ 582,099 June 30, 2024 2023 Property and equipment, net: United States $ 19,643 $ 16,475 International 215 274 Total property and equipment, net $ 19,858 $ 16,749 June 30, 2024 2023 Intangible assets, net: United States $ 38,008 $ 38,700 International — — Total intangible assets, net $ 38,008 $ 38,700 |
Schedule II - Valuation and Qua
Schedule II - Valuation and Qualifying Accounts | 12 Months Ended |
Jun. 30, 2024 | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |
Schedule II - Valuation and Qualifying Accounts | Schedule II: Valuation and Qualifying Accounts The activity in the allowance for doubtful accounts and the deferred tax asset valuation allowance are as follows (in thousands): Balance at the Charged to (1) Write-offs Balance at the end Allowance for doubtful accounts Fiscal year 2022 $ 1,010 $ 581 $ ( 55 ) $ 1,536 Fiscal year 2023 $ 1,536 $ 2,740 $ ( 554 ) $ 3,722 Fiscal year 2024 $ 3,722 $ 935 $ ( 2,551 ) $ 2,106 Deferred tax asset valuation allowance Fiscal year 2022 $ 8,193 $ 9 $ ( 1,042 ) $ 7,160 Fiscal year 2023 $ 7,160 $ 52,396 $ — $ 59,556 Fiscal year 2024 $ 59,556 $ 8,113 $ — $ 67,669 (1) Additions to the allowance for doubtful accounts and the valuation allowance are charged to expense. Additions to the allowance for sales returns are charged against revenue. All other schedules are omitted because they are not required or the required information is shown in the financial statements or notes thereto. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. |
Reclassification | Reclassification Certain amounts in fiscal year 2023 consolidated financial statements have been reclassified to conform with current year presentation. These reclassifications had no effect on previously reported totals for assets, liabilities, stockholders’ equity, cash flows or net income. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. These estimates are based on information available as of the date of the financial statements; therefore, actual results could differ from those estimates. |
Revenue Recognition | Revenue Recognition The Company derives revenue primarily from fees earned through the delivery of qualified inquiries such as clicks, leads, calls, applications, or customers. The Company recognizes revenue when the Company transfers promised goods or services to clients in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The Company recognizes revenue pursuant to the five-step framework contained in ASC 606, Revenue from Contracts with Customers: (i) identify the contract with a client; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations. As part of determining whether a contract exists, probability of collection is assessed on a client-by-client basis at the outset of the contract. Clients are subjected to a credit review process that evaluates the clients’ financial position and the ability and intention to pay. If it is determined from the outset of an arrangement that the client does not have the ability or intention to pay, the Company will conclude that a contract does not exist and will continuously reassess its evaluation until the Company is able to conclude that a contract does exist. Generally, the Company’s contracts specify the period of time as one month, but in some instances the term may be longer. However, for most of the Company’s contracts with clients, either party can terminate the contract at any time without penalty. Consequently, enforceable rights and obligations only exist on a day-to-day basis, resulting in individual daily contracts during the specified term of the contract or until one party terminates the contract prior to the end of the specified term. The Company has assessed the services promised in its contracts with clients and has identified one performance obligation, which is a series of distinct services. Depending on the client’s needs, these services consist of a specified or an unlimited number of clicks, leads, calls, applications, customers, etc. (hereafter collectively referred to as “marketing results”) to be delivered over a period of time. The Company satisfies these performance obligations over time as the services are provided. The Company does not promise to provide any other significant goods or services to its clients. Transaction price is measured based on the consideration that the Company expects to receive from a contract with a client. The Company’s contracts with clients contain variable consideration as the price for an individual marketing result varies on a day-to-day basis depending on the market-driven amount a client has committed to pay. However, because the Company ensures the stated period of its contracts does not generally span multiple reporting periods, the contractual amount within a period is based on the number of marketing results delivered within the period. Therefore, the transaction price for any given period is fixed and no estimation of variable consideration is required. If a marketing result delivered to a client does not meet the contractual requirements associated with that marketing result, the Company’s contracts allow for clients to return a marketing result generally within 5-10 days of having received the marketing result. Such returns are factored into the amount billed to the client on a monthly basis and consequently result in a reduction to revenue in the same month the marketing result is delivered. No warranties are offered to the Company’s clients. The Company does not allocate transaction price as the Company has only one performance obligation and its contracts do not generally span multiple periods. Taxes collected from clients and remitted to governmental authorities are not included in revenue. The Company elected to use the practical expedient which allows the Company to record sales commissions as expense as incurred when the amortization period would have been one year or less. The Company bills clients monthly in arrears for the marketing results delivered during the preceding month. The Company’s standard payment terms are 30-60 days. Consequently, the Company does not have significant financing components in its arrangements. Separately from the agreements the Company has with clients, the Company has agreements with Internet search companies, third-party publishers and strategic partners that it engages with to generate targeted marketing results for the Company’s clients. The Company receives a fee from its clients and separately pays a fee to the Internet search companies, third-party publishers and strategic partners. The Company evaluates whether it is the principal (i.e., report revenue on a gross basis) or agent (i.e., report revenue on a net basis). In doing so, the Company first evaluates whether it controls the goods or services before they are transferred to the clients. If the Company controls the goods or services before they are transferred to the clients, the Company is the principal in the transaction. As a result, the fees paid by the Company’s clients are recognized as revenue and the fees paid to its Internet search companies, third-party publishers and strategic partners are included in cost of revenue. If the Company does not control the goods or services before they are transferred to the clients, the Company is the agent in the transaction and recognizes revenue on a net basis. The Company has one subsidiary, CloudControlMedia, LLC (“CCM”) , which provides performance marketing agency and technology services to clients in financial services, education and other markets, recognizing revenue on a net basis. Determining whether the Company controls the goods or services before they are transferred to the clients may require judgment. |
Concentrations of Credit Risk | Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company’s investment portfolio consists of money market funds. Cash is deposited with financial institutions that management believes are creditworthy. To date, the Company has not experienced any material losses on its investment portfolio. The Company maintains contracts with its clients, most of which are cancelable with little or no prior notice. In addition, these contracts do not contain penalty provisions for cancellation before the end of the contract term. The Company had one client that accounted for 12 %, 20 % and 17 % of net revenue in fiscal years 2024, 2023 and 2022. The Company had two client s that accounted for 13 % and 11 % of net accounts receivable as of June 30, 2024. No other client accounted for 10 % or more of net revenue in fiscal years 2024, 2023 and 2022, or 10 % or more of net accounts receivable as of June 30, 2024 and 2023. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the reporting date. The Company estimates and categorizes the fair value of its financial instruments by applying the following hierarchy: Level 1 — Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to directly access. Level 2 — Valuations based on quoted prices for similar assets or liabilities; valuations for interest-bearing securities based on non-daily quoted prices in active markets; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 3 — Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The Company’s financial instruments consist principally of cash equivalents, accounts receivable, accounts payable, post-closing payments and contingent consideration related to acquisitions. The recorded values of the Company’s accounts receivable and accounts payable approximate their current fair values due to the relatively short-term nature of these accounts. See Note 5, Fair Value Measurements, for additional information regarding fair value measurements. |
Cash and Cash Equivalents | Cash and Cash Equivalents All highly liquid investments with maturities of three months or less at the date of purchase are classified as cash equivalents on the Company’s consolidated balance sheets. |
Accounts Receivable and Allowances | Accounts Receivable and Allowances The Company’s accounts receivable are derived from clients located principally in the United States. The Company performs ongoing credit evaluation of its customers and generally does not require collateral. The Company makes estimates of expected credit losses for the allowance for doubtful accounts and allowance for unbilled receivables based upon its assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The following table presents the changes in the Company’s allowance for credit losses for the periods indicated (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Balance at beginning of the year $ 2,092 $ 120 $ 120 Write-offs charged against the allowance ( 1,277 ) — — Provision for credit losses — 1,972 — Balance at end of the year $ 815 $ 2,092 $ 120 The revenue reserve was $ 1.3 million and $ 1.6 million as of June 30, 2024 and 2023. The total allowance for credit losses and revenue reserve was $ 2.1 million and $ 3.7 million as of June 30, 2024 and 2023. |
Property and Equipment | Property and Equipment Property and equipment are stated at cost less accumulated depreciation and amortization, and are depreciated on a straight-line basis over the estimated useful lives of the assets, as follows: Computer equipment 3 years Software 3 years Furniture and fixtures 3 to 5 years Leasehold improvements the shorter of the lease term or the estimated useful lives of the improvements |
Internal Software Development Costs | Internal Software Development Costs The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the development phase are capitalized and amortized over the product’s estimated useful life if the product is expected to have a useful life beyond six months . Costs associated with repair or maintenance of existing sites or the development of website content are included within cost of revenue in the Company’s consolidated statements of operations and comprehensive loss . The Company’s policy is to amortize capitalized internal software development costs on a product-by-product basis using the straight-line method over the estimated economic life of the application, which is generally two years . The Company capitalized internal software development costs of $ 10.9 million and $ 12.8 million in fiscal years 2024 and 2023. Amortization of internal software development costs is reflected within cost of revenue in the Company’s consolidated statements of operations and comprehensive loss . |
Leases | Leases At the commencement date of a lease, the Company recognizes lease liabilities which represent its obligation to make lease payments, and right-of-use (“ROU”) assets which represent its right to use the underlying asset during the lease term. The lease liability is measured at the present value of lease payments over the lease term. As the Company’s leases typically do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the lease commencement date. The ROU asset is measured at cost, which includes the initial measurement of the lease liability and initial direct costs incurred by the Company and excludes lease incentives. Lease liabilities are recorded in accrued liabilities and operating lease liabilities, noncurrent. ROU assets are recorded in operating lease right-of-use assets. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. Lease agreements that contain both lease and non-lease components are generally accounted for separately. The Company does not recognize lease liabilities and ROU assets for short-term leases with terms of twelve months or less. |
Acquisitions and Business Combinations | Acquisitions and Business Combinations In each acquisition transaction, the Company assesses whether the transaction should follow accounting guidance applicable to an asset acquisition or a business combination. This assessment requires an evaluation of whether the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets, resulting in an asset acquisition or, if not, resulting in a business combination. An asset acquisition is an acquisition of an asset, or a group of assets, that does not meet the definition of a business. The Company accounts for asset acquisitions using the cost accumulation and allocation model, whereby the costs of acquisition are allocated to the assets acquired on a relative fair value basis in accordance with the Company’s accounting policies. The Company accounts for business combinations using the acquisition method, which requires that the total consideration for each of the acquired business be allocated to the assets acquired and liabilities assumed based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair values of these identifiable assets and liabilities is recorded as goodwill. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. In determining the fair value of assets acquired and liabilities assumed in a business combination, the Company used the income approach to value its most significant acquired asset. Significant assumptions relating to the Company’s estimates in the income approach include base revenue, revenue growth rate net of client attrition, projected gross margin, discount rates, projected operating expenses and the future effective income tax rates. The valuations of our acquired businesses have been performed by a third-party valuation specialist under the Company management’s supervision. The Company believes that the estimated fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use. However, such assumptions are inherently uncertain and actual results could differ from those estimates. Future changes in our assumptions or the interrelationship of those assumptions may negatively impact future valuations. In future measurements of fair value, adverse changes in discounted cash flow assumptions could result in an impairment of goodwill or intangible assets that would require a non-cash charge to the consolidated statements of operations and comprehensive loss and may have a material effect on our financial condition and operating results. Acquisition related costs in a business combination are not considered part of the consideration, and are expensed as operating expense as incurred. Contingent consideration, if any, is measured at fair value initially on the acquisition date as well as subsequently at the end of each reporting period until settlement at the end of the assessment period. The Company includes the results of operations of the businesses acquired as of the beginning of the acquisition dates. |
Goodwill | Goodwill The Company conducts a test for the impairment of goodwill at the reporting unit level on at least an annual basis and whenever there are events or changes in circumstances that would more likely than not reduce the estimated fair value of a reporting unit below its carrying value. Application of the goodwill impairment test requires judgment, including the identification of reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value of each reporting unit. Significant judgments required to estimate the fair value of reporting units include estimating future cash flows and determining appropriate discount rates, growth rates, an appropriate control premium and other assumptions. Changes in these estimates and assumptions could materially affect the determination of fair value for each reporting unit which could trigger impairment. The Company performs its annual goodwill impairment test on April 30 and conducts a qualitative assessment to determine whether it is necessary to perform a quantitative goodwill impairment test. In assessing the qualitative factors, the Company considers the impact of key factors such as changes in the general economic conditions, changes in industry and competitive environment, stock price, actual revenue performance compared to previous years, forecasts and cash flow generation. The Company had one reporting unit for purposes of allocating and testing goodwill for fiscal year 2024. Based on the results of the qualitative assessment completed as of April 30, 2024, there were no indicators of impairment. |
Long-Lived Assets | Long-Lived Assets The Company evaluates long-lived assets, such as property and equipment and purchased intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If necessary, a quantitative test is performed that requires the application of judgment when assessing the fair value of an asset. When the Company identifies an impairment, it reduces the carrying amount of the asset to its estimated fair value based on a discounted cash flow approach or, when available and appropriate, to comparable market values. As of April 30, 2024, the Company evaluated its long-lived assets and concluded there were no indicators of impairment . The weighted-average useful life of intangible assets was 3.8 years as of June 30, 2024. |
Investments in Equity Securities | Investments in Equity Securities The Company’s investments in equity securities, which are reported within other assets, noncurrent, on the consolidated balance sheets, include investments in privately held companies without readily determinable market values. The Company adjusts the carrying value of its investments in equity securities to fair value when transactions for identical or similar investments of the same issuer are observable. All gains and losses on investments in equity securities, realized and unrealized, are recognized within other (expense) income, net on the Company’s consolidated statements of operations and comprehensive loss . The Company applies the equity method of accounting for investments in other entities when it exercises significant influence. Under the equity method, the Company’s share of each investee’s profit or loss is recognized within other (expense) income, net on the Company’s consolidated statements of operations and comprehensive loss . The Company applies the fair value measurement alternative for investments in other entities when it holds less than 20 % ownership in the entity and does not exercise significant influence. These investments consist of equity holdings in non-public companies and are recorded within other assets, noncurrent, on the consolidated balance sheets. The Company regularly reviews investments accounted for under the equity method and the fair value measurement alternative for possible impairment, which generally involves an analysis of the facts and changes in circumstances influencing the investment, expectations of the entity’s cash flows and capital needs, and the viability of its business model. The evaluation for impairment of investments in equity securities considers qualitative factors, including the financial condition and specific events related to an investee that may indicate the fair value of the investment is less than its carrying value. For fiscal year 2024, an impairment charge for investments in equity securities of $ 2.0 million was recorded within other (expense) income, net on the consolidated statement of operations and comprehensive loss. |
Income Taxes | Income Taxes The Company accounts for income taxes using an asset and liability approach to record deferred taxes. The Company’s deferred income tax assets represent temporary differences between the financial statement carrying amount and the tax basis of existing assets and liabilities that will result in deductible amounts in future years, including net loss carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets and liabilities are expected to be realized or settled. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized. The Company regularly assesses the realizability of our deferred tax assets. Judgment is required to determine whether a valuation allowance is necessary and the amount of such valuation allowance, if appropriate. The Company considers all available evidence, both positive and negative to determine, based on the weight of available evidence, whether it is more likely than not that some or all of the deferred tax assets will not be realized. In evaluating the need, or continued need, for a valuation allowance the Company considers, among other things, the nature, frequency and severity of current and cumulative taxable income or losses, forecasts of future profitability, and the duration of statutory carryforward periods. The Company’s judgments regarding future profitability may change due to future market conditions, changes in U.S. or international tax laws and other factors. The Company recognizes tax benefits from an uncertain tax position only if it is more likely than not, based on the technical merits of the position, that the tax position will be sustained on examination by the tax authorities. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Interest and penalties related to unrecognized tax benefits are recognized within income tax expense. |
Foreign Currency Translation | Foreign Currency Translation The Company’s foreign operations are subject to exchange rate fluctuations. The majority of the Company’s sales and expenses are denominated in U.S. dollars. The functional currency for the majority of the Company’s foreign subsidiaries is the U.S. dollar. For these subsidiaries, assets and liabilities denominated in foreign currency are remeasured into U.S. dollars at current exchange rates for monetary assets and liabilities and historical exchange rates for nonmonetary assets and liabilities. Net revenue, cost of revenue and expenses are generally remeasured at average exchange rates in effect during each period. Gains and losses from foreign currency remeasurement are included in other (expense) income, net in the Company’s consolidated statements of operations and comprehensive loss. Certain foreign subsidiaries designate the local currency as their functional currency. For those subsidiaries, the assets and liabilities are translated into U.S. dollars at exchange rates in effect at the balance sheet date. Income and expense items are translated at average exchange rates for the period. The foreign currency translation adjustments are included in accumulated other comprehensive loss as a separate component of stockholders’ equity. Foreign currency transaction gains and losses are recorded within other (expense) income, net in the Company’s consolidated statements of operations and comprehensive loss and were not material for any period presented. |
Comprehensive Loss | Comprehensive Loss Comprehensive loss consists of net loss and foreign currency translation adjustments from those subsidiaries not using the U.S. dollar as their functional currency. Comprehensive loss is disclosed as part of the statements of operations and comprehensive loss. |
Loss Contingencies | Loss Contingencies The Company is subject to the possibility of various loss contingencies arising in the ordinary course of business. Management considers the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as its ability to reasonably estimate the amount of loss, in determining loss contingencies. An estimated loss contingency is accrued when it is probable that an asset has been impaired or a liability has been incurred and the amount of loss can be reasonably estimated. The Company regularly evaluates current information available to its management to determine whether such accruals should be adjusted and whether new accruals are required. From time to time, the Company is involved in disputes, litigation and other legal actions. The Company records a charge equal to at least the minimum estimated liability for a loss contingency only when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements, and (ii) the range of loss can be reasonably estimated. The actual liability in any such matters may be materially different from the Company’s estimates, which could result in the need to adjust the liability and record additional expenses. |
Stock-Based Compensation | Stock-Based Compensation The Company measures and records the expense related to stock-based transactions based on the fair values of stock-based payment awards, as determined on the date of grant. The fair value of restricted stock units with a service condition (“service-based RSU”) is determined based on the closing price of the Company’s common stock on the date of grant. To estimate the fair value of stock options and purchase rights granted under the employee stock purchase plan (“ESPP”), the Company selected the Black-Scholes option pricing model. The fair value of restricted stock units with a service and performance condition (“performance-based RSU”) is determined based on the closing price of the Company’s common stock on the date of grant. Grant date as defined by ASC 718 is determined when the components that comprise the performance targets have been fully established. If a grant date has not been established, the compensation expense associated with the performance-based RSUs is re-measured at each reporting date based on the closing price of the Company’s common stock at each reporting date until the grant date has been established. In applying these models, the Company’s determination of the fair value of the award is affected by assumptions regarding a number of subjective variables. These variables include, but are not limited to, the Company’s expected stock price volatility over the term of the award and the employees’ actual and projected stock option exercise and pre-vesting employment termination behaviors. The Company recognizes stock-based compensation expense for options and service-based RSUs using the straight-line method, and for performance-based RSUs using the graded vesting method, based on awards ultimately expected to vest. The Company recognizes stock-based compensation expense for the purchase rights granted under the ESPP using the straight-line method over the offering period. The Company estimates future forfeitures at the date of grant. On an annual basis, the Company assesses changes to its estimate of expected forfeitures based on recent forfeiture activity. The effect of adjustments made to the forfeiture rates, if any, is recognized in the period that change is made. See Note 13, Stock Benefit Plans , for additional information regarding stock-based compensation. |
401(k) Savings Plan | 401(k) Savings Plan The Company sponsors a 401(k) defined contribution plan covering all U.S. employees. There were no employer contributions under this plan in fiscal years 2024 and 2023. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements Accounting Pronouncements Already Adopted In October 2021, the Financial Standards Accounting Board (FASB) issued Accounting Standards Update (ASU) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (ASU 2021-08), which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers , as if the acquirer had originated the contracts. The Company adopted ASU 2021-08 in the first quarter of fiscal year 2024 on a prospective basis. The adoption of this ASU did not have a material impact on the Company's financial statements. Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ( ASU 2023-07) which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal periods beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. The Company is currently evaluating the impact of this ASU on its financial statement disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topics 740): Improvements to Income Tax Disclosures (ASU 2023-09) to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its financial statement disclosures. ASU’s not included in the Company's disclosures were assessed and determined to be not applicable and material to the Company’s consolidated financial statements or disclosures. |
Net Income per Share | Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by using the weighted-average number of shares of common stock outstanding, including potential dilutive shares of common stock assuming the dilutive effect of outstanding stock options, unvested restricted stock units, and shares issuable related to the ESPP using the treasury stock method. |
Retirement of Treasury Stock | The Company’s accounting policy upon the r etirement of treasury stock is to deduct its par value from common stock and reduce additional paid-in capital by the amount recorded in additional paid-in capital when the stock was originally issued. |
Segment Information | Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker, its chief executive officer, reviews financial information presented on a consolidated basis, and no expense or operating income is evaluated at a segment level. Given the consolidated level of review by the Company’s chief executive officer, the Company operates as one reportable segment. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
Schedule of Allowance for Credit Losses | The following table presents the changes in the Company’s allowance for credit losses for the periods indicated (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Balance at beginning of the year $ 2,092 $ 120 $ 120 Write-offs charged against the allowance ( 1,277 ) — — Provision for credit losses — 1,972 — Balance at end of the year $ 815 $ 2,092 $ 120 |
Estimated Useful Lives of the Assets | Property and equipment are stated at cost less accumulated depreciation and amortization, and are depreciated on a straight-line basis over the estimated useful lives of the assets, as follows: Computer equipment 3 years Software 3 years Furniture and fixtures 3 to 5 years Leasehold improvements the shorter of the lease term or the estimated useful lives of the improvements |
Revenue (Tables)
Revenue (Tables) | 12 Months Ended |
Jun. 30, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Disaggregation of Net Revenue | The following table presents the Company’s net revenue disaggregated by vertical (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Net revenue: Financial Services $ 392,579 $ 379,723 $ 417,110 Home Services 211,944 193,133 158,805 Other Revenue 8,991 7,768 6,184 Total net revenue $ 613,514 $ 580,624 $ 582,099 |
Schedule of Contract Liabilities from Contracts with Clients | The following table provides information about contract liabilities from the Company’s contracts with its clients (in thousands): June 30, 2024 2023 Client deposits $ 1,344 $ 1,213 Deferred revenue — 9 Total $ 1,344 $ 1,222 |
Net Loss per Share (Tables)
Net Loss per Share (Tables) | 12 Months Ended |
Jun. 30, 2024 | |
Earnings Per Share [Abstract] | |
Calculation of Basic and Diluted Net Loss per Share | The following table presents the calculation of basic and diluted net loss per share: Fiscal Year Ended June 30, 2024 2023 2022 (In thousands, except per share data) Numerator: Net loss $ ( 31,331 ) $ ( 68,866 ) $ ( 5,248 ) Denominator: Weighted average shares of common stock used in computing 54,917 53,799 54,339 Weighted average effect of dilutive securities — — — Weighted average shares of common stock used in computing diluted net loss per share 54,917 53,799 54,339 Net loss per share: Basic and diluted (1) $ ( 0.57 ) $ ( 1.28 ) $ ( 0.10 ) Securities excluded from weighted average shares of common stock used in computing diluted net loss per share because the effect would have been anti-dilutive: (2) 4,453 4,247 3,557 (1) Diluted net loss per share does not reflect any potential common stock relating to stock options, restricted stock units, or shares issuable related to the ESPP due to net loss incurred in fiscal years 2024, 2023 and 2022. The assumed issuance of any additional shares would be anti-dilutive. (2) These weighted shares relate to anti-dilutive stock options, restricted stock units, and shares issuable related to the ESPP as calculated using the treasury stock method and could be dilutive in the future . |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Jun. 30, 2024 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value of Financial Instruments Measured at Fair Value on Recurring Basis | The following table presents the fair value of the Company’s financial instruments (in thousands): June 30, 2024 June 30, 2023 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets: Money market funds $ 2,215 $ — $ — $ 2,215 $ 16,910 $ — $ — $ 16,910 Liabilities: Post-closing payments related to acquisitions $ — $ 18,143 $ — $ 18,143 $ — $ 17,498 $ — $ 17,498 Contingent consideration related to acquisitions — — 2,466 2,466 — — 1,039 1,039 Total $ — $ 18,143 $ 2,466 $ 20,609 $ — $ 17,498 $ 1,039 $ 18,537 Reported as: Cash and cash equivalents $ 2,215 $ 16,910 Other Liabilities: Current $ 9,372 $ 7,875 Noncurrent 11,237 10,662 Total $ 20,609 $ 18,537 |
Schedule of Change in Contingent Consideration | The following table presents the changes in the contingent consideration (in thousands): Level 3 Balance at June 30, 2022 $ 1,787 Payments made during the period ( 748 ) Balance at June 30, 2023 1,039 Additions related to the acquisition of AquaVida (initial measurement) 2,100 Payments made during the period ( 673 ) Balance at June 30, 2024 $ 2,466 |
Acquisitions (Tables)
Acquisitions (Tables) | 12 Months Ended |
Jun. 30, 2024 | |
Best Company | |
Business Acquisition [Line Items] | |
Schedule of Consideration | The following table summarizes the consideration as of the acquisition date (in thousands): Estimated Fair Value Cash $ 2,510 Post-closing payments, net of imputed interest of $ 325 3,696 Promissory note adjustment 158 Total $ 6,364 |
Summary of Fair Values of Identifiable Intangible Assets Acquired and Estimated Useful Lives | The following table summarizes the components and allocation of the purchase price, the fair values and estimated useful lives of the identifiable assets acquired as of the date of the acquisition (in thousands): Estimated Estimated Shared assets license $ 5,228 10 years Client relationships 682 8 years Non-competition agreements 454 3 years Total $ 6,364 |
AquaVida | |
Business Acquisition [Line Items] | |
Schedule of Consideration | The following table summarizes the consideration as of the acquisition date (in thousands): Estimated Fair Value Cash $ 2,000 Post-closing payments, net of imputed interest of $ 535 3,465 Contingent consideration 2,100 Total $ 7,565 |
Summary of Fair Values of Identifiable Intangible Assets Acquired and Estimated Useful Lives | The following table summarizes the components and preliminary allocation of the purchase price, the fair values and estimated useful lives of the identifiable assets acquired as of the date of the acquisition (in thousands): Estimated Estimated Existing technology $ 1,900 5 years Client relationships 1,200 8 years Content 50 1 year Non-competition agreement 500 4 years Goodwill 3,915 Indefinite Total $ 7,565 |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 12 Months Ended |
Jun. 30, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Accounts Receivable, Net | Accounts receivable, net was comprised of the following (in thousands): June 30, 2024 2023 Accounts receivable, gross $ 113,892 $ 71,470 Less: Allowance for credit losses and revenue reserves ( 2,106 ) ( 3,722 ) Total accounts receivable, net $ 111,786 $ 67,748 |
Schedule of Prepaid Expenses and Other Assets | Prepaid expenses and other assets were comprised of the following (in thousands): June 30, 2024 2023 Prepaid expenses $ 6,217 $ 8,241 Income tax receivable 63 120 Other assets 533 1,418 Total prepaid expenses and other assets $ 6,813 $ 9,779 |
Property and Equipment, Net | Property and equipment, net was comprised of the following (in thousands): June 30, 2024 2023 Computer equipment $ 13,259 $ 12,236 Software 1,262 825 Furniture and fixtures 375 346 Leasehold improvements 3,889 1,377 Internal software development costs 29,474 18,568 Property and equipment, gross 48,259 33,352 Less: Accumulated depreciation and amortization ( 28,401 ) ( 16,603 ) Total property and equipment, net $ 19,858 $ 16,749 |
Accrued Liabilities | Accrued liabilities were comprised of the following (in thousands): June 30, 2024 2023 Accrued media costs $ 52,805 $ 27,302 Accrued compensation and related expenses 6,579 7,812 Accrued professional service and other business expenses 6,348 5,579 Operating lease liabilities, current 3,090 3,317 Deferred revenue (1) — 9 Total accrued liabilities $ 68,822 $ 44,019 (1) Accrued liabilities include deferred revenue of $ 9 thousand as of June 30, 2023, which previously has been presented as a separate component in the balance sheets. |
Other Liabilities, Noncurrent | Other liabilities, noncurrent were comprised of the following (in thousands): June 30, 2024 2023 Post-closing payments and contingent consideration related to acquisitions $ 11,237 $ 10,662 Income tax liabilities 6,089 5,493 Other liabilities 118 118 Total other liabilities, noncurrent $ 17,444 $ 16,273 |
Intangible Assets, Net and Go_2
Intangible Assets, Net and Goodwill (Tables) | 12 Months Ended |
Jun. 30, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets | Intangible assets, net consisted of the following (in thousands): June 30, 2024 June 30, 2023 Gross Net Gross Net Carrying Accumulated Carrying Carrying Accumulated Carrying Amount Amortization Amount Amount Amortization Amount Customer/publisher/advertiser relationships $ 93,511 $ ( 68,770 ) $ 24,741 $ 91,629 $ ( 61,025 ) $ 30,604 Content 43,106 ( 43,068 ) 38 43,056 ( 43,056 ) — Website/trade/domain names 25,422 ( 20,051 ) 5,371 25,422 ( 19,451 ) 5,971 Acquired technology and others 43,014 ( 35,156 ) 7,858 34,934 ( 32,809 ) 2,125 Total $ 205,053 $ ( 167,045 ) $ 38,008 $ 195,041 $ ( 156,341 ) $ 38,700 |
Amortization Expense | Future amortization expense for the Company’s intangible assets as of June 30, 2024 was as follows (in thousands): Fiscal Year Ending June 30, Amortization 2025 $ 9,533 2026 6,887 2027 5,864 2028 5,281 2029 4,234 Thereafter 6,209 Total $ 38,008 |
Changes in Carrying Amount of Goodwill | The changes in the carrying amount of goodwill were as follows (in thousands): Goodwill Balance at June 30, 2023 $ 121,141 Addition related to the acquisition of AquaVida 3,915 Balance at June 30, 2024 $ 125,056 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Jun. 30, 2024 | |
Income Tax Disclosure [Abstract] | |
Components of Loss Before Income Taxes | The components of loss before income taxes were as follows (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 US $ ( 31,110 ) $ ( 21,745 ) $ ( 6,022 ) Foreign 714 383 260 Total $ ( 30,396 ) $ ( 21,362 ) $ ( 5,762 ) |
Components of the Provision for (Benefit From) Income Taxes | The components of the provision for (benefit from) income taxes were as follows (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Current: Federal $ — $ — $ — State 125 143 176 Foreign 305 224 195 Total current provision for income taxes 430 367 371 Deferred: Federal 572 40,780 ( 1,032 ) State ( 104 ) 6,357 147 Foreign 37 — — Total deferred provision for (benefit from) income taxes 505 47,137 ( 885 ) Total provision for (benefit from) income taxes $ 935 $ 47,504 $ ( 514 ) |
Reconciliation Between Statutory Federal Income Tax Expense and Effective Income Tax Expense (Benefit) | The reconciliation between the statutory federal income tax expense and the Company’s effective income tax expense (benefit) was as follows (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Statutory federal income tax expense $ ( 6,359 ) $ ( 4,486 ) $ ( 1,210 ) States taxes, net of federal benefit ( 1,553 ) ( 752 ) ( 314 ) Foreign rate differential 106 61 11 Stock-based compensation expense (benefit) 25 676 ( 774 ) Change in valuation allowance 8,113 52,396 ( 1,034 ) Research and development credits ( 1,593 ) ( 1,847 ) ( 1,174 ) Disqualified compensation expense 1,363 744 1,806 Uncertain tax position 490 550 385 Expired attributes 188 273 261 Foreign deferred adjustment ( 6 ) — 1,354 Other 161 ( 111 ) 175 Effective income tax expense (benefit) $ 935 $ 47,504 $ ( 514 ) |
Components of Noncurrent Deferred Tax Assets and Liabilities, Net | The components of the noncurrent deferred tax assets and liabilities, net were as follows (in thousands): June 30, 2024 2023 Noncurrent deferred tax assets: Reserves and accruals $ 1,192 $ 1,716 Stock-based compensation expense 3,340 3,099 Net operating loss 38,590 35,430 Fixed assets 330 246 Tax credits 15,496 13,790 Operating lease liabilities 2,583 960 Research and development capitalized cost 12,985 7,221 Other 623 198 Total noncurrent deferred tax assets 75,139 62,660 Less: valuation allowance — long-term ( 67,669 ) ( 59,556 ) Total noncurrent deferred tax assets, net of valuation allowance 7,470 3,104 Noncurrent deferred tax liabilities: Intangibles ( 8,434 ) ( 5,303 ) Operating lease right-of-use assets ( 2,458 ) ( 718 ) Total noncurrent deferred tax liabilities ( 10,892 ) ( 6,021 ) Net deferred tax liabilities $ ( 3,422 ) $ ( 2,917 ) |
Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits | A reconciliation of the beginning and ending amounts of unrecognized tax benefits was as follows (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Balance at beginning of the year $ 6,030 $ 5,296 $ 4,756 Gross increases - current period tax positions 654 717 542 Gross decreases - prior period tax positions ( 40 ) — — Gross increases - prior period tax positions — 19 — Reductions as a result of lapsed statute of limitations — ( 2 ) ( 2 ) Balance at end of the year $ 6,644 $ 6,030 $ 5,296 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Jun. 30, 2024 | |
Leases [Abstract] | |
Components of Lease Expense | The components of lease expense were as follows (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Operating lease expense $ 4,220 $ 4,790 $ 5,172 Short-term lease expense 840 638 619 Variable lease expense (1) 565 666 676 Total lease expense $ 5,625 $ 6,094 $ 6,467 (1) Variable lease expense is primarily composed of common area maintenance charges. |
Supplemental Information Related to Operating Leases | Supplemental information related to operating leases was as follows (in thousands, except lease term and discount rate): Fiscal Year Ended June 30, 2024 2023 2022 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows used for operating leases $ 5,114 $ 5,860 $ 6,206 Lease liabilities arising from obtaining right-of-use assets Operating leases $ 11,026 $ 824 $ 564 Weighted average remaining lease term - operating leases 4.3 years 1.5 years 1.9 years Weighted average discount rate - operating leases 6.9 % 5.5 % 5.1 % |
Maturities of Operating Lease Liabilities | Maturities of operating lease liabilities as of June 30, 2024 were as follows (in thousands): Fiscal Year Ending June 30, Amount 2025 $ 3,511 2026 2,881 2027 2,750 2028 2,728 2029 1,457 Thereafter 209 Total minimum lease payments 13,536 Less: imputed interest ( 2,567 ) Present value of net minimum lease payments $ 10,969 Operating lease liabilities: Current (included in Accrued Liabilities) $ 3,090 Noncurrent 7,879 Total $ 10,969 |
Stock Benefit Plans (Tables)
Stock Benefit Plans (Tables) | 12 Months Ended |
Jun. 30, 2024 | |
Employee Stock Option [Member] | |
Schedule of Weighted Average Assumptions | The weighted-average Black-Scholes model assumptions and the weighted-average grant date fair value of stock options were as follows: Fiscal Year Ended June 30, 2024 2023 2022 Expected term (in years) 3.5 3.5 4.4 Expected volatility 52 % 55 % 58 % Expected dividend yield — — — Risk-free interest rate 4.6 % 3.8 % 1.0 % Grant date fair value $ 5.30 $ 4.85 $ 8.12 |
Stock Option Award Activity | The following table summarizes the stock option award activity under the plans: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding at June 30, 2022 547,619 $ 8.33 2.76 $ 2,110 Granted 11,306 11.18 Exercised ( 109,359 ) 5.37 Forfeited ( 2,439 ) 13.76 Expired ( 3,077 ) 10.49 Outstanding at June 30, 2023 444,050 $ 9.10 2.28 $ 1,283 Granted 9,808 12.54 Exercised ( 217,926 ) 4.21 Forfeited ( 15 ) 15.45 Expired ( 7,314 ) 7.78 Outstanding at June 30, 2024 228,603 $ 13.95 3.23 $ 912 Vested and expected-to-vest at June 30, 2024 (1) 227,879 $ 13.94 3.23 $ 912 Vested and exercisable at June 30, 2024 203,602 $ 13.33 3.15 $ 907 (1) The expected-to-vest options are the result of applying the pre-vesting forfeiture assumption to total outstanding options . |
Schedule of Total Intrinsic Value, Cash Received and Actual Tax Benefit of All Options Exercised | The following table summarizes the total intrinsic value, the cash received and the actual tax benefit of options exercised (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Intrinsic value $ 1,561 $ 693 $ 4,262 Cash received 918 587 1,850 Tax benefit — — 725 |
Service-based RSU [Member] | |
Schedule of RSU Activity | The following table summarizes the service-based RSU activity under the plans: Shares Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding at June 30, 2022 1,890,481 $ 14.33 1.32 $ 19,018 Granted 1,896,618 11.06 Vested ( 778,233 ) 15.42 Forfeited ( 109,707 ) 13.18 Outstanding at June 30, 2023 2,899,159 $ 11.95 1.30 $ 25,600 Granted 1,887,379 9.68 Vested ( 1,222,938 ) 12.32 Forfeited ( 141,733 ) 11.24 Outstanding at June 30, 2024 3,421,867 $ 10.59 1.26 $ 56,769 |
Performance-based RSU [Member] | |
Schedule of RSU Activity | The following table summarizes the performance-based RSU activity under the 2010 Incentive Plan: Shares Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding at June 30, 2022 1,223,977 $ 13.32 1.12 $ 12,313 Granted 308,000 8.83 Vested ( 504,086 ) 13.44 Forfeited ( 149,420 ) 13.47 Outstanding at June 30, 2023 878,471 $ 11.66 1.05 $ 7,757 Granted 616,000 16.59 Vested ( 291,628 ) 14.47 Forfeited ( 186,158 ) 9.48 Outstanding at June 30, 2024 1,016,685 $ 14.24 1.12 $ 16,867 |
Employee Stock Purchase Plan [Member] | |
Schedule of Fair Value of Purchase Rights | The fair value of the purchase rights for the ESPP are estimated on the date of grant using the Black-Scholes model with the following assumptions: Fiscal Year Ended June 30, 2024 2023 2022 Expected term (in years) 0.5 - 2.0 0.5 - 2.0 0.5 - 2.0 Expected volatility 48 % - 58 % 48 % - 57 % 48 % - 64 % Expected dividend yield — — — Risk-free interest rate 4.5 % - 5.5 % 2.9 % - 5.0 % 0.3 % - 1.0 % Grant date fair value $ 2.97 - $ 6.73 $ 3.77 - $ 8.11 $ 3.72 - $ 5.33 |
Segment Information (Tables)
Segment Information (Tables) | 12 Months Ended |
Jun. 30, 2024 | |
Segment Reporting [Abstract] | |
Net Revenue and Long-Lived Assets by Geographic Area | The following tables summarize the net revenue and long-lived assets by geographic area (in thousands): Fiscal Year Ended June 30, 2024 2023 2022 Net revenue: United States $ 607,373 $ 570,703 $ 559,984 International 6,141 9,921 22,115 Total net revenue $ 613,514 $ 580,624 $ 582,099 June 30, 2024 2023 Property and equipment, net: United States $ 19,643 $ 16,475 International 215 274 Total property and equipment, net $ 19,858 $ 16,749 June 30, 2024 2023 Intangible assets, net: United States $ 38,008 $ 38,700 International — — Total intangible assets, net $ 38,008 $ 38,700 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Additional Information (Detail) | 12 Months Ended | |||
Apr. 30, 2024 USD ($) | Jun. 30, 2024 USD ($) Client Segment | Jun. 30, 2023 USD ($) Client | Jun. 30, 2022 USD ($) Client | |
Summary Of Significant Accounting Policies [Line Items] | ||||
Maximum period for classifying as cash and cash equivalents | 3 months | |||
Revenue Reserve | $ 1,300,000 | $ 1,600,000 | ||
Allowance for credit losses and revenue reserve | $ 2,100,000 | 3,700,000 | ||
Costs incurred in development phase are capitalized and amortized period | 6 months | |||
Maximum period from the acquisition date for recording adjustments to the assets acquired and liabilities assumed | 1 year | |||
Number of reporting units | Segment | 1 | |||
Goodwill impairment | $ 0 | $ 0 | 0 | |
Impairment of long-lived assets | $ 0 | |||
Weighted-average useful life of intangible assets | 3 years 9 months 18 days | |||
Impairment charge of investment in equity security | $ 2,000,000 | 0 | $ 0 | |
Employer contributions to defined contribution plan | $ 0 | 0 | ||
Maximum [Member] | ||||
Summary Of Significant Accounting Policies [Line Items] | ||||
Fair value method investment ownership percentage | 20% | |||
Software Development [Member] | ||||
Summary Of Significant Accounting Policies [Line Items] | ||||
Estimated useful lives of the assets | 2 years | |||
Software capitalized amount | $ 10,900,000 | $ 12,800,000 | ||
Customer Concentration Risk [Member] | Net revenue [Member] | Client One [Member] | ||||
Summary Of Significant Accounting Policies [Line Items] | ||||
Number of clients accounted for more than 10% of net revenue | Client | 1 | 1 | 1 | |
Concentration risk percentage accounted by major clients | 12% | 20% | 17% | |
Customer Concentration Risk [Member] | Net revenue [Member] | Other Client [Member] | ||||
Summary Of Significant Accounting Policies [Line Items] | ||||
Concentration risk percentage accounted by major clients | 10% | 10% | 10% | |
Number of clients accounted for more than 10% of net revenue | Client | 0 | 0 | 0 | |
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Client One [Member] | ||||
Summary Of Significant Accounting Policies [Line Items] | ||||
Concentration risk percentage accounted by major clients | 13% | |||
Number of clients that accounted for 10% or more of net accounts receivable | Client | 1 | |||
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Client Two [Member] | ||||
Summary Of Significant Accounting Policies [Line Items] | ||||
Concentration risk percentage accounted by major clients | 11% | |||
Number of clients that accounted for 10% or more of net accounts receivable | Client | 1 | |||
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Other Client [Member] | ||||
Summary Of Significant Accounting Policies [Line Items] | ||||
Concentration risk percentage accounted by major clients | 10% | 10% | ||
Number of clients accounted for more than 10% of net accounts receivable | Client | 0 | 0 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Schedule of Allowance for Credit Losses (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Accounting Policies [Abstract] | |||
Balance at beginning of the year | $ 2,092 | $ 120 | $ 120 |
Write-offs charged against the allowance | (1,277) | 0 | 0 |
Provision for credit losses | 0 | 1,972 | 0 |
Balance at end of the year | $ 815 | $ 2,092 | $ 120 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Estimated Useful Lives of the Assets (Detail) | 12 Months Ended |
Jun. 30, 2024 | |
Computer equipment [Member] | |
Property, Plant and Equipment [Line Items] | |
Estimated useful lives of the assets | 3 years |
Furniture and fixtures [Member] | Minimum [Member] | |
Property, Plant and Equipment [Line Items] | |
Estimated useful lives of the assets | 3 years |
Furniture and fixtures [Member] | Maximum [Member] | |
Property, Plant and Equipment [Line Items] | |
Estimated useful lives of the assets | 5 years |
Leasehold improvements [Member] | |
Property, Plant and Equipment [Line Items] | |
Estimated useful lives of leasehold improvements | the shorter of the lease term or the estimated useful lives of the improvements |
Software [Member] | |
Property, Plant and Equipment [Line Items] | |
Estimated useful lives of the assets | 3 years |
Revenue - Schedule of Disaggreg
Revenue - Schedule of Disaggregation of Net Revenue (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Disaggregation Of Revenue [Line Items] | |||
Net revenue | $ 613,514 | $ 580,624 | $ 582,099 |
Financial Services [Member] | |||
Disaggregation Of Revenue [Line Items] | |||
Net revenue | 392,579 | 379,723 | 417,110 |
Home Services [Member] | |||
Disaggregation Of Revenue [Line Items] | |||
Net revenue | 211,944 | 193,133 | 158,805 |
Other Revenue [Member] | |||
Disaggregation Of Revenue [Line Items] | |||
Net revenue | $ 8,991 | $ 7,768 | $ 6,184 |
Revenue - Schedule of Contract
Revenue - Schedule of Contract Liabilities from Contracts with Clients (Detail) - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract] | ||
Client deposits | $ 1,344 | $ 1,213 |
Deferred revenue | 0 | 9 |
Total | $ 1,344 | $ 1,222 |
Revenue - Additional Informatio
Revenue - Additional Information (Detail) $ in Millions | 12 Months Ended |
Jun. 30, 2024 USD ($) | |
Revenue from Contract with Customer [Abstract] | |
Revenue recognized | $ 18.5 |
Change in amount of advance consideration received from customers | $ 18.7 |
Net Loss per Share - Calculatio
Net Loss per Share - Calculation of Basic and Diluted Net Loss per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | ||
Numerator: | ||||
Net loss | $ (31,331) | $ (68,866) | $ (5,248) | |
Denominator: | ||||
Weighted-average shares of common stock used in computing basic net loss per share | 54,917 | 53,799 | 54,339 | |
Weighted average effect of dilutive securities: | ||||
Weighted average effect of dilutive securities | 0 | 0 | 0 | |
Weighted average shares of common stock used in computing diluted net loss per share | 54,917 | 53,799 | 54,339 | |
Net loss per share: | ||||
Basic | [1] | $ (0.57) | $ (1.28) | $ (0.1) |
Diluted | [1] | $ (0.57) | $ (1.28) | $ (0.1) |
Securities excluded from weighted-average shares used in computing diluted net loss per share because the effect would have been anti-dilutive | [2] | 4,453 | 4,247 | 3,557 |
[1] Diluted net loss per share does not reflect any potential common stock relating to stock options, restricted stock units, or shares issuable related to the ESPP due to net loss incurred in fiscal years 2024, 2023 and 2022. The assumed issuance of any additional shares would be anti-dilutive. These weighted shares relate to anti-dilutive stock options, restricted stock units, and shares issuable related to the ESPP as calculated using the treasury stock method and could be dilutive in the future . |
Fair Value Measurements - Sched
Fair Value Measurements - Schedule of Fair Value of Financial Instruments Measured at Fair Value on Recurring Basis (Detail) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Liabilities: | ||
Total Liabilities | $ 20,609 | $ 18,537 |
Cash and cash equivalents | 2,215 | 16,910 |
Other Liabilities: | ||
Other Liabilities | 20,609 | 18,537 |
Current [Member] | ||
Other Liabilities: | ||
Other Liabilities | 9,372 | 7,875 |
Non Current [Member] | ||
Other Liabilities: | ||
Other Liabilities | 11,237 | 10,662 |
Post-closing payments related to acquisitions [Member] | ||
Liabilities: | ||
Total Liabilities | 18,143 | 17,498 |
Contingent consideration related to acquisitions [Member] | ||
Liabilities: | ||
Total Liabilities | 2,466 | 1,039 |
Money market funds [Member] | ||
Assets: | ||
Total Assets | 2,215 | 16,910 |
Level 1 [Member] | ||
Liabilities: | ||
Total Liabilities | 0 | 0 |
Level 1 [Member] | Post-closing payments related to acquisitions [Member] | ||
Liabilities: | ||
Total Liabilities | 0 | 0 |
Level 1 [Member] | Contingent consideration related to acquisitions [Member] | ||
Liabilities: | ||
Total Liabilities | 0 | 0 |
Level 1 [Member] | Money market funds [Member] | ||
Assets: | ||
Total Assets | 2,215 | 16,910 |
Level 2 [Member] | ||
Liabilities: | ||
Total Liabilities | 18,143 | 17,498 |
Level 2 [Member] | Post-closing payments related to acquisitions [Member] | ||
Liabilities: | ||
Total Liabilities | 18,143 | 17,498 |
Level 2 [Member] | Contingent consideration related to acquisitions [Member] | ||
Liabilities: | ||
Total Liabilities | 0 | 0 |
Level 2 [Member] | Money market funds [Member] | ||
Assets: | ||
Total Assets | 0 | 0 |
Level 3 [Member] | ||
Liabilities: | ||
Total Liabilities | 2,466 | 1,039 |
Level 3 [Member] | Post-closing payments related to acquisitions [Member] | ||
Liabilities: | ||
Total Liabilities | 0 | 0 |
Level 3 [Member] | Contingent consideration related to acquisitions [Member] | ||
Liabilities: | ||
Total Liabilities | 2,466 | 1,039 |
Level 3 [Member] | Money market funds [Member] | ||
Assets: | ||
Total Assets | $ 0 | $ 0 |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Information (Detail) - USD ($) | Jun. 30, 2024 | Jun. 30, 2023 |
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract] | ||
Fair value, assets, level 1 to level 2 transfers, amount | $ 0 | $ 0 |
Fair value, assets, level 2 to level 1 transfers, amount | 0 | 0 |
Fair value, liabilities, level 1 to level 2 transfers, amount | 0 | 0 |
Fair value, liabilities, level 2 to level 1 transfers, amount | 0 | 0 |
Fair value liabilities level 3 to level 1 transfers, amount | 0 | 0 |
Fair value assets level 3 to level 1 transfers, amount | $ 0 | $ 0 |
Fair Value Measurements - Sch_2
Fair Value Measurements - Schedule of Change in Contingent Consideration (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | |||
Additions related to the acquisition of AquaVida (initial measurement) | $ 0 | $ 0 | $ (926) |
Level 3 [Member] | |||
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | |||
Beginning balance | 1,039 | $ 1,787 | |
Payments made during the period | (673) | (748) | |
Additions related to the acquisition of AquaVida (initial measurement) | 2,100 | ||
Ending balance | $ 2,466 | $ 1,039 |
Acquisitions - Additional Infor
Acquisitions - Additional Information (Detail) - USD ($) $ in Thousands | 3 Months Ended | |||
Mar. 01, 2024 | Jan. 04, 2024 | Jun. 30, 2022 | Dec. 31, 2021 | |
Best Company | ||||
Business Acquisition [Line Items] | ||||
Closing date of acquisition | Jan. 04, 2024 | |||
Cash paid upon closing | $ 2,510 | |||
Business Combination, post-closing payments | 4,000 | |||
Business combination, incremental convertible promissory note | $ 1,000 | |||
Business combination, deferred consideration payment period | 2 years | |||
Business combination, deferred consideration payment description | post-closing payments, payable in equal annual installments over two years, with the first installment payable twelve months following the date of closing. | |||
AquaVida | ||||
Business Acquisition [Line Items] | ||||
Closing date of acquisition | Mar. 01, 2024 | |||
Cash paid upon closing | $ 2,000 | |||
Business Combination, post-closing payments | $ 4,000 | |||
Business combination, deferred consideration payment period | 4 years | |||
Business combination, deferred consideration payment description | post-closing payments, payable in equal annual installments over a four-year period, with the first installment payable twelve months following the date of closing. | |||
Home Services Client Vertical | ||||
Business Acquisition [Line Items] | ||||
Closing date of acquisition | Jun. 30, 2022 | Dec. 31, 2021 | ||
Cash paid upon closing | $ 1,000 | $ 1,000 | ||
Business Combination, post-closing payments | $ 1,000 | $ 2,000 | ||
Business combination, deferred consideration payment period | 2 years | 2 years | ||
Business combination, deferred consideration payment description | post-closing payments, payable in equal annual installments over a two-year period, with the first installment paid in the fourth quarter of fiscal year 2023 | post-closing payments, payable in equal annual installments over a two-year period, with the first installment paid in the second quarter of fiscal year 2023 |
Acquisitions - Schedule of Cons
Acquisitions - Schedule of Consideration (Detail) - USD ($) $ in Thousands | Mar. 01, 2024 | Jan. 04, 2024 |
Best Company | ||
Business Acquisition [Line Items] | ||
Cash paid upon closing | $ 2,510 | |
Post-closing payments, net of imputed interest | 3,696 | |
Section 338 election payment to Modernize | 158 | |
Total | $ 6,364 | |
AquaVida | ||
Business Acquisition [Line Items] | ||
Cash paid upon closing | $ 2,000 | |
Post-closing payments, net of imputed interest | 3,465 | |
Section 338 election payment to Modernize | 2,100 | |
Total | $ 7,565 |
Acquisitions - Schedule of Co_2
Acquisitions - Schedule of Consideration (Parenthetical) (Detail) - USD ($) $ in Thousands | Mar. 01, 2024 | Jan. 04, 2024 |
Best Company | ||
Business Acquisition [Line Items] | ||
Deferred Consideration Imputed Interest | $ 325 | |
AquaVida | ||
Business Acquisition [Line Items] | ||
Deferred Consideration Imputed Interest | $ 535 |
Acquisitions - Schedule of Allo
Acquisitions - Schedule of Allocation of Purchase Price and Estimated Useful Lives of Identifiable Assets Acquired (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||
Mar. 01, 2024 | Jan. 04, 2024 | Jun. 30, 2024 | Jun. 30, 2023 | |
Business Acquisition [Line Items] | ||||
Weighted-average useful life of intangible assets | 3 years 9 months 18 days | |||
Goodwill | $ 125,056 | $ 121,141 | ||
Best Company | ||||
Business Acquisition [Line Items] | ||||
Estimated Fair Value | $ 6,364 | |||
Best Company | Shared assets license | ||||
Business Acquisition [Line Items] | ||||
Estimated Fair Value | $ 5,228 | |||
Weighted-average useful life of intangible assets | 10 years | |||
Best Company | Customer/publisher/advertiser relationships [Member] | ||||
Business Acquisition [Line Items] | ||||
Estimated Fair Value | $ 682 | |||
Weighted-average useful life of intangible assets | 8 years | |||
Best Company | Non-competition agreements | ||||
Business Acquisition [Line Items] | ||||
Estimated Fair Value | $ 454 | |||
Weighted-average useful life of intangible assets | 3 years | |||
AquaVida | ||||
Business Acquisition [Line Items] | ||||
Estimated Fair Value | $ 7,565 | |||
Goodwill | 3,915 | |||
AquaVida | Existing technology | ||||
Business Acquisition [Line Items] | ||||
Estimated Fair Value | $ 1,900 | |||
Weighted-average useful life of intangible assets | 5 years | |||
AquaVida | Customer/publisher/advertiser relationships [Member] | ||||
Business Acquisition [Line Items] | ||||
Estimated Fair Value | $ 1,200 | |||
Weighted-average useful life of intangible assets | 8 years | |||
AquaVida | Content [Member] | ||||
Business Acquisition [Line Items] | ||||
Estimated Fair Value | $ 50 | |||
Weighted-average useful life of intangible assets | 1 year | |||
AquaVida | Non-competition agreements | ||||
Business Acquisition [Line Items] | ||||
Estimated Fair Value | $ 500 | |||
Weighted-average useful life of intangible assets | 4 years |
Balance Sheet Components - Acco
Balance Sheet Components - Accounts Receivable, Net (Detail) - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Accounts Receivable, after Allowance for Credit Loss, Current [Abstract] | ||
Accounts receivable, gross | $ 113,892 | $ 71,470 |
Less: Allowance for credit losses and revenue reserves | (2,106) | (3,722) |
Total accounts receivable, net | $ 111,786 | $ 67,748 |
Balance Sheet Components - Sche
Balance Sheet Components - Schedule of Prepaid Expenses and Other Assets Current (Detail) - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Prepaid Expense and Other Assets, Current [Abstract] | ||
Prepaid expenses | $ 6,217 | $ 8,241 |
Income tax receivable | 63 | 120 |
Other assets | 533 | 1,418 |
Total prepaid expenses and other assets | $ 6,813 | $ 9,779 |
Balance Sheet Components - Prop
Balance Sheet Components - Property and Equipment, Net (Detail) - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 48,259 | $ 33,352 |
Less: Accumulated depreciation and amortization | (28,401) | (16,603) |
Total property and equipment, net | 19,858 | 16,749 |
Computer equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 13,259 | 12,236 |
Software [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 1,262 | 825 |
Furniture and fixtures [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 375 | 346 |
Leasehold improvements [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 3,889 | 1,377 |
Internal software development costs [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 29,474 | $ 18,568 |
Balance Sheet Components - Addi
Balance Sheet Components - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Property Plant And Equipment Useful Life And Values [Abstract] | |||
Depreciation expense | $ 3 | $ 2.8 | $ 2.4 |
Amortization expense related to internal software development costs | $ 10.2 | $ 5.3 | $ 3 |
Balance Sheet Components - Accr
Balance Sheet Components - Accrued Liabilities (Detail) - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Payables and Accruals [Abstract] | ||
Accrued media costs | $ 52,805 | $ 27,302 |
Accrued compensation and related expenses | 6,579 | 7,812 |
Accrued professional service and other business expenses | 6,348 | 5,579 |
Operating lease liabilities, current | $ 3,090 | $ 3,317 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Other Liabilities, Current | Other Liabilities, Current |
Deferred revenue | $ 9 | |
Total accrued liabilities | $ 68,822 | $ 44,019 |
Balance Sheet Components - Ac_2
Balance Sheet Components - Accrued Liabilities (Parenthetical) (Details) $ in Thousands | Jun. 30, 2023 USD ($) |
Payables and Accruals [Abstract] | |
Deferred revenue | $ 9 |
Balance Sheet Components - Othe
Balance Sheet Components - Other Liabilities, Noncurrent (Details) - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Payables and Accruals [Abstract] | ||
Post-closing payments and contingent consideration related to acquisitions | $ 11,237 | $ 10,662 |
Income tax liabilities | 6,089 | 5,493 |
Other liabilities | 118 | 118 |
Total other liabilities, noncurrent | $ 17,444 | $ 16,273 |
Intangible Assets, Net and Go_3
Intangible Assets, Net and Goodwill - Intangible Assets (Detail) - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 205,053 | $ 195,041 |
Accumulated Amortization | (167,045) | (156,341) |
Net Carrying Amount | 38,008 | 38,700 |
Customer/publisher/advertiser relationships [Member] | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 93,511 | 91,629 |
Accumulated Amortization | (68,770) | (61,025) |
Net Carrying Amount | 24,741 | 30,604 |
Content [Member] | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 43,106 | 43,056 |
Accumulated Amortization | (43,068) | (43,056) |
Net Carrying Amount | 38 | 0 |
Website/trade/domain names [Member] | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 25,422 | 25,422 |
Accumulated Amortization | (20,051) | (19,451) |
Net Carrying Amount | 5,371 | 5,971 |
Acquired technology and others [Member] | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 43,014 | 34,934 |
Accumulated Amortization | (35,156) | (32,809) |
Net Carrying Amount | $ 7,858 | $ 2,125 |
Intangible Assets, Net and Go_4
Intangible Assets, Net and Goodwill - Additional Information (Detail) - USD ($) | 12 Months Ended | |||
Apr. 30, 2024 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Amortization of intangible assets | $ 10,700,000 | $ 11,100,000 | $ 11,600,000 | |
Additions to goodwill | 3,915,000 | 0 | ||
Goodwill impairment | $ 0 | $ 0 | $ 0 |
Intangible Assets, Net and Go_5
Intangible Assets, Net and Goodwill - Amortization Expense (Detail) - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | ||
2025 | $ 9,533 | |
2026 | 6,887 | |
2027 | 5,864 | |
2028 | 5,281 | |
2029 | 4,234 | |
Thereafter | 6,209 | |
Net Carrying Amount | $ 38,008 | $ 38,700 |
Intangible Assets, Net and Go_6
Intangible Assets, Net and Goodwill - Changes in Carrying Amount of Goodwill (Detail) - USD ($) | 12 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Balance at June 30, 2023 | $ 121,141,000 | |
Addition related to the acquisition of AquaVida | 3,915,000 | $ 0 |
Balance at June 30, 2024 | $ 125,056,000 | $ 121,141,000 |
Income Taxes - Components of Lo
Income Taxes - Components of Loss Before Income Taxes (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Tax Disclosure [Abstract] | |||
US | $ (31,110) | $ (21,745) | $ (6,022) |
Foreign | 714 | 383 | 260 |
Loss before income taxes | $ (30,396) | $ (21,362) | $ (5,762) |
Income Taxes - Components of th
Income Taxes - Components of the Provision for (Benefit From) Income Taxes (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Current: | |||
Federal | $ 0 | $ 0 | $ 0 |
State | 125 | 143 | 176 |
Foreign | 305 | 224 | 195 |
Total current provision for income taxes | 430 | 367 | 371 |
Deferred: | |||
Federal | 572 | 40,780 | (1,032) |
State | (104) | 6,357 | 147 |
Foreign | 37 | 0 | 0 |
Total deferred provision for (benefit from) income taxes | 505 | 47,137 | (885) |
Total provision for (benefit from) income taxes | $ 935 | $ 47,504 | $ (514) |
Income Taxes - Reconciliation B
Income Taxes - Reconciliation Between Statutory Federal Income Tax Expense and Effective Income Tax Expense (Benefit) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Tax Disclosure [Abstract] | |||
Statutory federal income tax expense | $ (6,359) | $ (4,486) | $ (1,210) |
States taxes, net of federal benefit | (1,553) | (752) | (314) |
Foreign rate differential | 106 | 61 | 11 |
Stock-based compensation expense (benefit) | 25 | 676 | (774) |
Change in valuation allowance | 8,113 | 52,396 | (1,034) |
Research and development credits | (1,593) | (1,847) | (1,174) |
Disqualified compensation expense | 1,363 | 744 | 1,806 |
Uncertain tax position | 490 | 550 | 385 |
Expired attributes | 188 | 273 | 261 |
Foreign deferred adjustment | (6) | 0 | 1,354 |
Other | 161 | (111) | 175 |
Total provision for (benefit from) income taxes | $ 935 | $ 47,504 | $ (514) |
Income Taxes - Components of No
Income Taxes - Components of Noncurrent Deferred Tax Assets and Liabilities, Net (Detail) - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Noncurrent deferred tax assets: | ||
Reserves and accruals | $ 1,192 | $ 1,716 |
Stock-based compensation expense | 3,340 | 3,099 |
Net operating loss | 38,590 | 35,430 |
Fixed assets | 330 | 246 |
Tax credits | 15,496 | 13,790 |
Operating lease liabilities | 2,583 | 960 |
Research and development capitalized cost | 12,985 | 7,221 |
Other | 623 | 198 |
Total noncurrent deferred tax assets | 75,139 | 62,660 |
Less: valuation allowance - long-term | (67,669) | (59,556) |
Total noncurrent deferred tax assets, net of valuation allowance | 7,470 | 3,104 |
Noncurrent deferred tax liabilities: | ||
Intangibles | (8,434) | (5,303) |
Operating lease right-of-use assets | (2,458) | (718) |
Total noncurrent deferred tax liabilities | (10,892) | (6,021) |
Net deferred tax liabilities | $ (3,422) | $ (2,917) |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Jun. 30, 2024 | |
Income Tax Contingency [Line Items] | ||
Net deferred tax liabilities | $ 2,917 | $ 3,422 |
Valuation allowance - long-term | 59,556 | 67,669 |
Operating loss carry-forwards | 35,430 | 38,590 |
Unrecognized tax benefits that if recognized would affect the effective tax rate | 1,100 | |
Non-cash charge to income tax expense | 52,400 | |
Other Liabilities, Noncurrent [Member] | ||
Income Tax Contingency [Line Items] | ||
Net deferred tax liabilities | 2,900 | 3,400 |
Interest and penalties related to the unrecognized tax benefits | 1,600 | |
Federal [Member] | ||
Income Tax Contingency [Line Items] | ||
Operating loss carry-forwards | 141,500 | 152,900 |
Operating loss carry-forwards indefinite | $ 69,500 | |
Operating loss carry-forwards, expire date | Jun. 30, 2035 | |
Tax credit carry-forwards, expire date | Jun. 30, 2034 | |
State [Member] | ||
Income Tax Contingency [Line Items] | ||
Operating loss carry-forwards | 83,800 | $ 97,600 |
Operating loss carry-forwards, expire date | Jun. 30, 2025 | |
India [Member] | International [Member] | ||
Income Tax Contingency [Line Items] | ||
Operating loss carry-forwards | $ 1,800 | |
Operating loss carry-forwards, expire date | Jun. 30, 2025 | |
California [Member] | State [Member] | ||
Income Tax Contingency [Line Items] | ||
Research and development carry-forwards | $ 12,200 | $ 10,800 |
Minimum [Member] | Federal [Member] | ||
Income Tax Contingency [Line Items] | ||
Open tax year | 2013 | |
Minimum [Member] | International [Member] | ||
Income Tax Contingency [Line Items] | ||
Open tax year | 2020 | |
Maximum [Member] | Federal [Member] | ||
Income Tax Contingency [Line Items] | ||
Open tax year | 2024 | |
Maximum [Member] | International [Member] | ||
Income Tax Contingency [Line Items] | ||
Open tax year | 2024 |
Income Taxes - Reconciliation o
Income Taxes - Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Tax Disclosure [Abstract] | |||
Unrecognized Tax Benefits, Beginning Balance | $ 6,030 | $ 5,296 | $ 4,756 |
Gross increases - current period tax positions | 654 | 717 | 542 |
Gross decreases - prior period tax positions | (40) | 0 | 0 |
Gross increases - prior period tax positions | 0 | 19 | 0 |
Reductions as a result of lapsed statute of limitations | 0 | (2) | (2) |
Unrecognized Tax Benefits, Ending Balance | $ 6,644 | $ 6,030 | $ 5,296 |
Leases - Additional Information
Leases - Additional Information (Detail) | Jun. 30, 2024 |
Lessee, Lease, Description [Line Items] | |
Lessee, operating lease, renewal term | 5 years |
Leases - Components of Lease Ex
Leases - Components of Lease Expense (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | ||
Lease, Cost [Abstract] | ||||
Operating lease expense | $ 4,220 | $ 4,790 | $ 5,172 | |
Short-term lease expense | 840 | 638 | 619 | |
Variable lease expense | [1] | 565 | 666 | 676 |
Total lease expense | $ 5,625 | $ 6,094 | $ 6,467 | |
[1] Variable lease expense is primarily composed of common area maintenance charges. |
Leases - Supplemental Informati
Leases - Supplemental Information Related to Operating Leases (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Cash paid for amounts included in the measurement of lease liabilities | |||
Operating cash flows used for operating leases | $ 5,114 | $ 5,860 | $ 6,206 |
Lease liabilities arising from obtaining right-of-use assets | |||
Operating leases | $ 11,026 | $ 824 | $ 564 |
Weighted average remaining lease term - operating leases | 4 years 3 months 18 days | 1 year 6 months | 1 year 10 months 24 days |
Weighted average discount rate - operating leases | 6.90% | 5.50% | 5.10% |
Leases - Maturities of Operatin
Leases - Maturities of Operating Lease Liabilities (Detail) - USD ($) $ in Thousands | Jun. 30, 2024 | Jun. 30, 2023 |
Lease, Cost [Abstract] | ||
2025 | $ 3,511 | |
2026 | 2,881 | |
2027 | 2,750 | |
2028 | 2,728 | |
2029 | 1,457 | |
Thereafter | 209 | |
Total minimum lease payments | 13,536 | |
Less imputed interest | (2,567) | |
Present value of net minimum lease payments | 10,969 | |
Operating lease liabilities: | ||
Current (included in Accrued Liabilities) | $ 3,090 | $ 3,317 |
Operating Lease Liability Current Statement Of Financial Position [Extensible List] | Other liabilities | Other liabilities |
Noncurrent | $ 7,879 | $ 1,261 |
Total | $ 10,969 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - USD ($) | 12 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | ||
Estimated fair value of indemnification agreements | $ 0 | $ 0 |
Estimated fair value of indemnity provisions | 0 | $ 0 |
Letter of credit agreement with a financial institution that is used as collateral for the Company's corporate headquarters' operating lease | $ 300,000 | |
Letters of credit automatically renew annually without amendment on the annual expiration date | 30 days |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Apr. 30, 2022 | |
Equity Class Of Treasury Stock [Line Items] | |||
Treasury Stock, Value, Acquired, Cost Method | $ 2,200 | $ 4,053 | |
Retirement of treasury stock, Shares | 247,618 | 403,193 | |
Retirement of treasury stock | $ 2,200 | $ 4,100 | |
Stock repurchased but unsettled, value | $ 100 | ||
Stock repurchased but unsettled, shares | 10,000 | ||
April 2022 Stock Repurchase Program [Member] | |||
Equity Class Of Treasury Stock [Line Items] | |||
Stock repurchase program outstanding shares of common stock authorized to repurchase | $ 40,000 | ||
Repurchase of common stock | 247,618 | 403,193 | |
Treasury Stock Acquired, Average Cost Per Share | $ 8.85 | $ 10.02 | |
Treasury Stock, Value, Acquired, Cost Method | $ 2,200 | $ 4,100 | |
Treasury Stock Broker Commission | $ 0.03 | $ 0.03 | |
Stock repurchase program, amount remained available for stock repurchase | $ 16,800 |
Stock Benefit Plans - Additiona
Stock Benefit Plans - Additional Information (Detail) - USD ($) | 1 Months Ended | 12 Months Ended | |||
Nov. 30, 2009 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Stock-based compensation expense | $ 23,701,000 | $ 18,786,000 | $ 18,506,000 | ||
Tax benefits realized | 0 | $ 0 | $ 800,000 | ||
Total unrecognized compensation expense related to stock options | $ 200,000 | ||||
Unvested stock options weighted average period (in years) | 10 months 24 days | ||||
2010 Incentive Plan [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
General contractual term for stock options granted to employees | 7 years | ||||
Common stock reserved for issuance | 23,125,612 | ||||
Percentage of common stock reserved for issuance to be increased | 5% | ||||
Maximum number of shares that may be issued | 30,000,000 | ||||
Shares available for issuance | 9,396,038 | ||||
Directors' Plan [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Common stock reserved for issuance | 4,598,838 | ||||
Shares available for issuance | 1,921,954 | ||||
Number of common stock shares increased in reserve for annual basis | 200,000 | ||||
2021 ESPP [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Common stock reserved for issuance | 2,164,999 | ||||
Shares available for issuance | 1,568,959 | ||||
Shares of common stock allowed to purchase at a discount through payroll deductions | 15% | ||||
Purchase of common stock at a percentage of price per share | 85% | ||||
Maximum number of common stock, participant may purchase during purchase period | 2,500 | ||||
Maximum value of common stock, participant may purchase in each calendar year | $ 25,000 | ||||
Employee payroll contributions accrued | $ 1,200,000 | ||||
Purchase period end date | Aug. 24, 2024 | ||||
Shares of common stock purchased | 317,394 | ||||
Employee Stock Option | 2010 Incentive Plan [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting period | 4 years | ||||
Stock options vesting percentage one year from the date of grant | 25% | ||||
Remaining stock option vesting percentage over the three years period thereafter | 75% | ||||
Employee Stock Option | Directors' Plan [Member] | Annual Grant [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting period | 1 year | 1 year | |||
Employee Stock Option | Directors' Plan [Member] | Initial Grant [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting period | 4 years | ||||
Restricted stock units [Member] | 2010 Incentive Plan [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting period | 4 years | ||||
RSUs vesting percentage one year from the date of grant | 25% | ||||
Remaining RSUs vesting quarterly thereafter percentage | 6.25% | ||||
Restricted stock units [Member] | Directors' Plan [Member] | Annual Grant [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting period | 1 year | ||||
Restricted stock units [Member] | Directors' Plan [Member] | Initial Grant [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting period | 4 years | ||||
Service-based RSU [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Total unrecognized compensation expense | $ 26,000,000 | ||||
Performance-based RSU [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Total unrecognized compensation expense | $ 4,700,000 |
Stock Benefit Plans - Schedule
Stock Benefit Plans - Schedule of Weighted Average Assumptions (Detail) - Employee Stock Option - $ / shares | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected term (in years) | 3 years 6 months | 3 years 6 months | 4 years 4 months 24 days |
Expected volatility | 52% | 55% | 58% |
Expected dividend yield | 0% | 0% | 0% |
Risk-free interest rate | 4.60% | 3.80% | 1% |
Grant date fair value | $ 5.30 | $ 4.85 | $ 8.12 |
Stock Benefit Plans - Schedul_2
Stock Benefit Plans - Schedule of Stock Option Award Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | ||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||
Beginning balance, Shares | 444,050 | 547,619 | ||
Granted, Shares | 9,808 | 11,306 | ||
Exercised, Shares | (217,926) | (109,359) | ||
Forfeited, Shares | (15) | (2,439) | ||
Expired, Shares | (7,314) | (3,077) | ||
Ending balance, Shares | 228,603 | 444,050 | 547,619 | |
Vested and expected-to-vest at June 30, 2024, Shares | [1] | 227,879 | ||
Vested and exercisable at June 30, 2024, Shares | 203,602 | |||
Beginning balance, Weighted Average Exercise Price | $ 9.10 | $ 8.33 | ||
Granted, Weighted Average Exercise Price | 12.54 | 11.18 | ||
Exercised, Weighted Average Exercise Price | 4.21 | 5.37 | ||
Forfeited, Weighted Average Exercise Price | 15.45 | 13.76 | ||
Expired, Weighted Average Exercise Price | 7.78 | 10.49 | ||
Ending balance, Weighted Average Exercise Price | 13.95 | $ 9.10 | $ 8.33 | |
Vested and expected-to-vest at June 30, 2024, Weighted Average Exercise Price | [1] | 13.94 | ||
Vested and exercisable at June 30, 2024, Weighted Average Exercise Price | $ 13.33 | |||
Weighted Average Remaining Contractual Life (In years) | 3 years 2 months 23 days | 2 years 3 months 10 days | 2 years 9 months 3 days | |
Vested and expected-to-vest at June 30, 2024, Weighted Average Remaining Contractual Life (In years) | [1] | 3 years 2 months 23 days | ||
Vested and exercisable at June 30, 2024,Weighted Average Remaining Contractual Life (In years) | 3 years 1 month 24 days | |||
Aggregate Intrinsic Value | $ 912 | $ 1,283 | $ 2,110 | |
Vested and expected-to-vest at June 30, 2024, Aggregate Intrinsic Value | [1] | 912 | ||
Vested and exercisable at June 30, 2024, Aggregate Intrinsic Value | $ 907 | |||
[1] The expected-to-vest options are the result of applying the pre-vesting forfeiture assumption to total outstanding options |
Stock Benefit Plans - Schedul_3
Stock Benefit Plans - Schedule of Total Intrinsic Value, Cash Received and Actual Tax Benefit of All Options Exercised (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||
Intrinsic value | $ 1,561 | $ 693 | $ 4,262 |
Cash received | 918 | 587 | 1,850 |
Tax benefit | $ 0 | $ 0 | $ 725 |
Stock Benefit Plans - Schedul_4
Stock Benefit Plans - Schedule of RSU Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Service-based RSU [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Beginning balance, Shares | 2,899,159 | 1,890,481 | |
Granted, Shares | 1,887,379 | 1,896,618 | |
Vested, Shares | (1,222,938) | (778,233) | |
Forfeited, Shares | (141,733) | (109,707) | |
Ending balance, Shares | 3,421,867 | 2,899,159 | 1,890,481 |
Beginning balance, Weighted Average Grant Date Fair Value | $ 11.95 | $ 14.33 | |
Granted, Weighted Average Grant Date Fair Value | 9.68 | 11.06 | |
Vested, Weighted Average Grant Date Fair Value | 12.32 | 15.42 | |
Forfeited, Weighted Average Grant Date Fair Value | 11.24 | 13.18 | |
Ending balance, Weighted Average Grant Date Fair Value | $ 10.59 | $ 11.95 | $ 14.33 |
Weighted Average Remaining Contractual Life (In years) | 1 year 3 months 3 days | 1 year 3 months 18 days | 1 year 3 months 25 days |
Aggregate Intrinsic Value, Outstanding | $ 56,769 | $ 25,600 | $ 19,018 |
Performance-based RSU [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Beginning balance, Shares | 878,471 | 1,223,977 | |
Granted, Shares | 616,000 | 308,000 | |
Vested, Shares | (291,628) | (504,086) | |
Forfeited, Shares | (186,158) | (149,420) | |
Ending balance, Shares | 1,016,685 | 878,471 | 1,223,977 |
Beginning balance, Weighted Average Grant Date Fair Value | $ 11.66 | $ 13.32 | |
Granted, Weighted Average Grant Date Fair Value | 16.59 | 8.83 | |
Vested, Weighted Average Grant Date Fair Value | 14.47 | 13.44 | |
Forfeited, Weighted Average Grant Date Fair Value | 9.48 | 13.47 | |
Ending balance, Weighted Average Grant Date Fair Value | $ 14.24 | $ 11.66 | $ 13.32 |
Weighted Average Remaining Contractual Life (In years) | 1 year 1 month 13 days | 1 year 18 days | 1 year 1 month 13 days |
Aggregate Intrinsic Value, Outstanding | $ 16,867 | $ 7,757 | $ 12,313 |
Stock Benefit Plans - Schedul_5
Stock Benefit Plans - Schedule of Fair Value of Purchase Rights (Detail) - Employee Stock Purchase Plan [Member] - $ / shares | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Minimum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected term (in years) | 6 months | 6 months | 6 months |
Expected volatility | 48% | 48% | 48% |
Expected dividend yield | 0% | 0% | 0% |
Risk-free interest rate | 4.50% | 2.90% | 0.30% |
Grant date fair value | $ 2.97 | $ 3.77 | $ 3.72 |
Maximum [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected term (in years) | 2 years | 2 years | 2 years |
Expected volatility | 58% | 57% | 64% |
Expected dividend yield | 0% | 0% | 0% |
Risk-free interest rate | 5.50% | 5% | 1% |
Grant date fair value | $ 6.73 | $ 8.11 | $ 5.33 |
Segment Information - Additiona
Segment Information - Additional Information (Detail) | 12 Months Ended |
Jun. 30, 2024 Segment | |
Segment Reporting [Abstract] | |
Number of reportable segments | 1 |
Segment Information - Net Reven
Segment Information - Net Revenue and Long-Lived Assets by Geographic Area (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | |
Net revenue: | |||
Total net revenue | $ 613,514 | $ 580,624 | $ 582,099 |
Property and equipment, net: | |||
Total property and equipment, net | 19,858 | 16,749 | |
Intangible assets, net: | |||
Intangible assets, net | 38,008 | 38,700 | |
United States [Member] | |||
Net revenue: | |||
Total net revenue | 607,373 | 570,703 | 559,984 |
Property and equipment, net: | |||
Total property and equipment, net | 19,643 | 16,475 | |
Intangible assets, net: | |||
Intangible assets, net | 38,008 | 38,700 | |
International [Member] | |||
Net revenue: | |||
Total net revenue | 6,141 | 9,921 | $ 22,115 |
Property and equipment, net: | |||
Total property and equipment, net | 215 | 274 | |
Intangible assets, net: | |||
Intangible assets, net | $ 0 | $ 0 |
Schedule II - Valuation and Q_2
Schedule II - Valuation and Qualifying Accounts (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2022 | ||
Allowance for doubtful accounts [Member] | ||||
Valuation and Qualifying Accounts Disclosure [Line Items] | ||||
Balance at the beginning of the year | $ 3,722 | $ 1,536 | $ 1,010 | |
Charged to expenses/against revenue | [1] | 935 | 2,740 | 581 |
Write-offs net of recoveries | (2,551) | (554) | (55) | |
Balance at the end of the year | 2,106 | 3,722 | 1,536 | |
Deferred tax asset valuation allowance [Member] | ||||
Valuation and Qualifying Accounts Disclosure [Line Items] | ||||
Balance at the beginning of the year | 59,556 | 7,160 | 8,193 | |
Charged to expenses/against revenue | [1] | 8,113 | 52,396 | 9 |
Write-offs net of recoveries | 0 | 0 | (1,042) | |
Balance at the end of the year | $ 67,669 | $ 59,556 | $ 7,160 | |
[1] Additions to the allowance for doubtful accounts and the valuation allowance are charged to expense. Additions to the allowance for sales returns are charged against revenue. |